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ANGIOTENSIN II IN THE REGULATION OF RENAL FUNCTION
Previous studies have provided evidence that the renin-angiotensin system exerts
numerous physiological actions. In this thesis, attention is focussed on the direct
actions of exogenous and endogenous angiotensin II (All) in the regulation of renal
function,
iotensin
A review of the literature pertaining to the biochemistry of the renin-ang-
system, the actions of angiotensin II and angiotensin III (AIII) on renal
function, the driving forces for fluid absorption by the proximal tubule and some of
the factors which influence proximal tubular fluid absorption is presented.
The experiments described in this thesis were designed to evaluate the effects of
angiotensin II on renal function in the anaesthetised rat prepared for micropuncture.
Systemic infusion of a pressor dose (100 ng.min *)
increase in both urine flow and urinary sodium excretion,
iated with a significant reduction in proximal tubular
of All resulted in a marked
These changes were assoc-
fluid reabsorption. However,
when the renal perfusion pressure was prevented from increasing, the same dose of All
resulted in a significant reduction in both urine flow and urinary sodium excretion.
These changes occurred in the absence of a significant alteration in the rate of prox¬
imal tubular fluid reabsorption. These results indicate that the natriuretic response
to All is dependent upon the increase in renal perfusion pressure.
Infusion of sub-pressor doses (5 and 10 ng.min 1) of All resulted in a subtle
antidiuresis and antinatriuresis when the effects of the peptide were compared to the
effects of infusion of saline alone. In addition, infusion of All at a rate of 10
1 significantly reduced glomerulur filtration rate. However, infusion of these




Further experiments were carried out
(infusion 0.9% NaCl I.V. at a rate of 150 yl.min
in which rats were acutely volume expanded
*) and/or chronically sodium loaded
(replacing drinking water with saline solution) in an attempt to suppress endogenous
angiotensin production and thereby demonstrate a pronounced antinatriuretic response
to infused hormone. Infusion of sub-pressor doses (0.1, 1 and 5 ng.min l) of All in
chronically sodium loaded rats did not significantly alter urine flow, urinary sodium
excretion, glomerular filtration rate or proximal tubular fluid reabsorption.
In acutely volume expanded chronically sodium loaded rats, infusion of All at















the same conditions, infusion of
(SQ14,225), resulted in a significant
reduction in the percentage of filtered
ng.min 1) during continuing converting enzyme
antidiuresis and antinatriuresis. These excretory










m n o r significant
proximal tubular fluid reabsorption.
enzyme inhibitor, captopril
urinary sodium excretion and a
reabsorbed. Infusion of All (10
blockade resulted in a significant
responses were associated with a
and a restoration of fractional
sodium reabsorption to pre-captopril levels.
These results are consistent with the concept that the anaesthetised rat produces
of angiotensin that are almost optimal for maximal stimulation of proximalamounts
reabsorption
i t si
and sodium retention and
ti l
that it is endogenousnecessary to suppress
angiotensin production in order to demonstrate a pronounced antinatriuretic effect of
infused hormone. In addition, the results provide no evidence in support of the con¬
cept that the mechanism whereby systemic All reduces urine flow and sodium excretion
involves a direct stimulatory effect of the peptide on proximal tubular fluid reabsorp
tion.
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INTRODUCTION
The components of the renin-angiotensin system are summarised in
Fig. I. Renin is an acid protease which cleaves renin substrate (angio-
tensinogen) to produce the decapeptide angiotensin I (AI), which is then
converted to the octapeptide angiotensin II (All) by the dipeptidase,
angiotensin converting enzyme. An aspartate aminopeptidase, angio-
tensinase A, cleaves the NH^-terminal aspartate residue from All to form
the heptapeptide angiotensin III (AIII).
Although it is generally accepted that the major physiological
actions of the renin-angiotensin system are mediated by All, the hepta¬
peptide AIII does exert a wide range of activity in various tissues.
The renin-angiotensin system is thought to be involved in the
regulation of arterial blood pressure and extracellular fluid volume.
Extracellular fluid volume depletion, caused by a variety of circum¬
stances, leads to the activation of numerous mechanisms involved with
the conservation of water and electrolytes and with body fluid and
arterial pressure homeostasis (De Wardener, 1978; Navar, 1984). One of
the more powerful of these is the renin-angiotensin system, which serves
as a highly sensitive index of the state of sodium balance (Davis and
Freeman, 1976; Aguilera and Catt, 1978). All is a major stimulus for
the biosynthesis and secretion of the sodium-retaining steroid aldo¬
sterone (Laragh et al., 1960; Biron et al., 1961; Page and Bumpus, 1974;
Aguilera and Catt, 1978; Mendelsohn and Kachel, 1980), and much of it's
sodium conserving influence is mediated by the renal effects of aldo¬
sterone.
Aldosterone influences sodium and potassium transport in the distal
tubule and collecting duct segments by altering the activity of the
Na+/K+-ATPase located predominantly on the basolateral side of tubular
+ . +
cells and also by facilitating Na /K exchange processes on the luminal
membranes (Ludens and Fanestil, 1976; Edelman, 1979). However, the
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action of aldosterone is relatively slow and requires a latent period of
45 to 120 minutes before onset (Barger et al. , 1958; Ganong and Mulrow,
1958; Ludens, and Fanestil, 1976).
It is generally accepted that sodium depletion or volume
contraction results in increases in circulating renin, All and
aldosterone levels and an increase in the sensitivity of the aldosterone
secretory response to All. Conversely, sodium loading or extracellular
fluid volume expansion results in decreases in circulating renin, All
and aldosterone levels and a decrease in the sensitivity of the
steroidogenic response to All. Directional changes in the number of
adrenal All receptors parallel the changes in adrenal responsiveness to
All (Douglas and Catt, 1976; Aguilera and Catt, 1978). Several studies
have documented that circulating All is a major regulator of adrenal All
receptor number during changes in sodium balance and that changes in All
binding are a major determinant of altered responsiveness to All
(Douglas and Catt, 1976; Aguilera and Catt, 1978; Hauger et al, 1978;
Douglas and Brown, 1982). Thus, as a major physiological regulator of
aldosterone biosynthesis and secretion, All can be considered an
important hormone influencing the basal long-term sodium transport
activity of the distal nephron during varying states of sodium balance.
However, it is well recognised that the actions of All are not
restricted to stimulation of aldosterone secretion. All acts directly
on cardiac and vascular smooth muscle to stimulate contraction, and
increases circulating catecholamines by an action on autonomic ganglia,
sympathetic nerve endings and the adrenal medulla (Farr and Grupp, 1971;
Peach, 1971; Bonnardeaux and Regoli, 1974; Regoli et al. , 1974). All
acts on the central nervous system to increase sympathetic nervous
system activity and thus arterial blood pressure (Bickerton and Buckley,
1961; Severs et al., 1966; Reid et al., 1982; Hartle and Brody, 1984).
Other actions of the peptide on the CNS include stimulation of thirst,
salt appetite, arginine vasopressin release and inhibition of renin and
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aldosterone secretion (Malvin, 1971; Keil et al., 1975; Chiaraviglio,
1976; Fitzsimons et al. , 1978; Brooks and Malvin, 1980; Reid et al.,
1982).
In addition, All has been reported to alter both electrogenic and
electroneutral salt transport by various epithelial tissues (McAfee and
Locke, 1967; Davies et al., 1970; Bolton et al. , 1975; Healy et al.,
1976; Harris and Young, 1977; Levens et al., 1981b; Schuster et al.,
1984). Furthermore, it has been demonstrated that the peptide exerts
direct effects on the kidney to alter the renal excretion of sodium and
water (Barraclough, 1965; Barraclough et al., 1967; Navar and Langford,
1974; Levens et al., 1981a).
Although the direct effects of All on renal function have been
studied extensively (Navar and Langford, 1974; Levens et al., 1981a)
there is still controversy as to the principal intrarenal site of action
of All and the contribution of the renin-angiotensin system to the
regulation of renal function.
This thesis is concerned with the role of All in the regulation of
renal function. In Section I, attention is focussed on the different
components of the renin-angiotensin system and the effects of angio¬
tensins II and III on renal function. Because part of the work of this
thesis is concerned with the effects of systemic infusions of All on
proximal tubular fluid reabsorption, there is also a brief review of the
driving forces for fluid absorption by the proximal tubule and some of
the factors involved in the control of proximal tubular reabsorption.
The experimental work described in Sections 3-6 was designed to
evaluate the effects of All on renal function in the anaesthetised rat
prepared for micropuncture, and to assess the possible mechanism (s)
whereby All alters renal function. The results from these experiments
are discussed in relation to the concept that All exerts major actions
in the regulation of renal function.
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FIG I THE RENIN-ANGIQTENSN SYSTEM
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Renin substrate or angiotensinogen is a glycoprotein normally
present in the blood and is part of the ct2~gl°bulin fraction of plasma
(Plentl et al., 1943). Renin substrate was first assumed to be
synthesised by the liver by Page et al., (19A1) and Leloir et al.,
(1942). This was later demonstrated in the isolated perfused liver
(Nasjletti and Masson, 1971), in rat liver slices (Freeman and
Rostorfer, 1972) and in isolated hepatocytes (Weigand et al., 1977).
Ganten et al. , (1972) reported renin substrate in dog brain, but showed
that none of the components of the renin-angiotensin system could cross
the blood brain barrier and concluded that there was an intrinsic
angiotensin producing system in the brain. Renin substrate has also
been detected in the renal lymph of rats (Horky et al., 1971) and in
specific subcellular granules in rat kidney cortex (Morris and Johnston,
1976). More recently, using immunocytochemistry, Richoux et al., (1983)
demonstrated that renin substrate was present in rat kidney as granular
formations in the cells of proximal convoluted tubules, although no
substrate was detected in the juxtaglomerular apparatus. However, it is
not known whether the presence of substrate in the kidney is due to
local synthesis or to uptake from the plasma.
PURIFICATION AND STRUCTURE
Renin substrate was first purified by Skeggs et al. , (1963) from
hog plasma. Using a purification process which included acidification
to pH 2.5, five different forms of substrate were isolated, all of which
were glycoproteins with a molecular weight of approximately 58,000. The
different forms had similar amino acid compositions but varied in their
glucosamine, neutral hexose and sialic acid content (Skeggs et al.,
1963).
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Recently both rat and human renin substrate were purified (Printz
and Printz, 1977; Eggena et al., 1978; Hilgenfeldt and Hackenthal, 1979;
Tewksbury et al. , 1981). Both were found to be glycoproteins, with
molecular weights varying from 52-60,000 depending on the technique
used, and with different isoelectric points ranging from 4.3 to 5.0.
Two major forms of renin substrate have been purified from rat plasma
(Bouhnik et al. , 1981; Hilgenfeldt and Hackenthal, 1982; Voigt et al. ,
1982). Similar heterogeneity was observed in the substrate in both the
CSF and plasma of man and rat, suggesting that the observed differences
were not due to isolation artifacts. Physiological variations in renin
substrate such as the increases induced by bilateral nephrectomy or
oestrogen administration were found not to alter its physicochemical
characteristics (Menard et al. , 1974a) although forms of substrate with
molecular weights exceeding 55-77,000 were found during pregnancy
(Gordon et al. , 1976) and oestrogen treatment (Tewksbury and Dart,
1981).
The renin substrate molecule from horse plasma has been degraded
with trypsin to yield the NH^-terminal tetradecapeptide which is
hydrolysed by renin at the Leu^-Leu^ bond to yield Al (Skeggs et al. ,
1957) (Fig.l). The structure of the tetradecapeptide has been determined
and the molecule synthesised. The tetradecapeptide isolated possessed
full substrate activity (Skeggs et al., 1958). The structure of the
NH^-terminal sequence has also been determined in both rat and human
substrate (Bouhnik et al., 1981; Tewksbury et al., 1981). The structure
of the last ten amino acids corresponds to that of horse Al although
human substrate has a renin cleavage site different from hog and rat
substrate.
The structural requirements of renin for its substrate have been
studied by comparison of the activity of renin on various peptide
analogues representing portions of the tetradecapeptide (Skeggs et al.,
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1968; Marshall, 1976). Several synthetic peptides have proved effective
inhibitors of renin, both in vivo and in vitro (Burton et al., 1980;
Szelke et al., 1982).
PHYSIOLOGICAL ROLE OF RENIN SUBSTRATE
An alteration in renin substrate level may lead to changes in renal
function and arterial blood pressure as a result ot altered Al and Ail
production. When renin substrate level increases, the negative feedback
which normally exists between All and renin secretion should rapidly
reduce renin secretion (De Champlain et al. , 1966) so that the All
production level is kept constant while the level of plasma renin
substrate is higher and that of plasma renin lower. However, in
reality, this does not happen and the physiological effects of
variations in renin substrate on renal function and blood pressure have
been well documented. Indeed, elevated plasma All levels and reduced
renal blood flow were reported in non-hypertensive women receiving
oestroprogestational contraceptives, ie, in women with elevated plasma
substrate levels (Menard et al., 1974b; Hollenberg et al., 1976). Also,
renin substrate was found to cause renal vasoconstriction in the rabbit
kidney and the isolated perfused rat kidney (Krahe et al., 1970; Regoli,
1972). In addition, the role of renin substrate in the maintenance of
arterial blood pressure in the rat was demonstrated by the reduction in
blood pressure induced by the injection of renin substrate antibodies
(Gardes et al., 1982).
VARIATIONS IN PLASMA CONCENTRATION
Plasma renin substrate concentration decreases after adrenalectomy,
hepatectomy and hypophysectomy (Nasjletti and Masson, 1971; Hasegawa et
al., 1973; Reid et al., 1973) and increases after bilateral nephrectomy
(Leloir et al., 1940; Carretero and Gross, 1967), during pregnancy
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(Gould et al., 1966; Helmer and Judson, 1967), in malignant hypertension
(Gould and Green, 1971; Rosset et al. , 1973), in severe hypoxia (Gould
and Goodman, 1970) and after administration of ACTH, adrenal cortical
hormones, oestrogens and All (Helmer and Griffith, 1952; Menard et al.,
1970; Krakoff and Eisenfeld, 1977; Reid, 1977). The mechanism
controlling plasma substrate level is not known, although it has been
proposed that it involves regulation of hepatic synthesis and not the
rate of utilisation by circulating renin (Nasjletti and Masson, 1971;
1972; 1973; Bing, 1972).
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RENIN
Tigerstedt and Bergman (1898) first used the name renin to indicate
a saline-extractable pressor substance obtained from kidney homogenates.
In 1934, Goldblatt et al. , demonstrated that hypertension could be
induced in experimental animals by the partial ligation of a renal
artery. They also showed that the manoeuvre resulted in the appearance
in the renal venous blood of a directly pressor substance on injection
into other animals. However, the mechanism of renin's action remained
unclear until Page and Helmer (1940) demonstrated that it was probably
an enzyme which acted upon another substance to release an active
principle which they called angiotonin. Braun-Menendez et al., (1940)
working independently made a similar observation, but named the active
principle hypertensin. The active substance was later called angio¬
tensin, a synthesis of the terras angiotonin and hypertensin.
Renin catalyses the formation of a decapeptide, Al (Skeggs et al.,
1954) which is the first in a series of peptides generated by a cascade
of enzymes working in concert, ie, the renin-angiotensin system cascade
(Fig.1).
DISTRIBUTION
Renin (renin isoenzymes) has been found in many different tissues,
although it is predominantly located in the kidney.
It is generally accepted that renin is synthesised and stored by
specialised cells, the juxtaglomerular cells, of the renal afferent
arteriole in intimate contact with the distal tubule (Goormaghtigh,
1939; Edelman and Hartroft, 1961; Robertson et al., 1965; Johnston et
al., 1973; Silverman and Barajas 1974; Taugner et al. , 1982a; 1982b).
The juxtaglomerular cells are thought to be modified smooth muscle cells
because they contain bundles of fibrils and attachment bodies similar to
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those of smooth muscle cells (Latta, 1973). As the distal tubule
approaches the vascular pole of the glomerulus it comes into direct
contact with the juxtaglomerular cells and the arterioles. The distal
tubule cells are modified and those in apposition to the glomerulus are
columnar in shape and are densely packed. This appearance gives rise to
the term macula densa cells. Collectively the juxtaglomerular cells,
the afferent glomerular arteriole and the macula densa segment of the
distal tubule are termed the juxtaglomerular apparatus (Hatt, 1967;
Barajas, 1970; Rouiller and Orci, 1971; Latta, 1973).
Using micropuncture and microdissection techniques, it has been
shown that renin is released from the cells of the afferent arteriole
(juxtaglomerular cells) and that renin activity is absent from other
cells of the juxtaglomerular apparatus (Faarup, 1968; 1971; Ogino et
al., 1967). Similar findings were reported by Hartroft et al., (1964)
using immunological techniques combined with fluorescence microscopy.
Cook (1967) further localised renin to the granules within the
juxtaglomerular cells themselves by removing the granules from these
cells with a micro-pipette. On incubation of the granules with renin
substrate angiotensin was produced, thus demonstrating the presence of
renin activity in the granules. The granularity within the
juxtaglomerular cells has been used as an index of their synthetic and
secretory activity (Davis and Freeman, 1976).
Renin is released from the granules into the afferent arteriolar
lumen (Horky et al., 1971) and probably also into the interstitial space
(Horky et al. , 1973; Morgan and Davis, 1975; Morgan and Gillies, 1977).
The secretion of renin into the renal interstitium would allow enough
time for the local generation of Al and All and would be consistent with
an action of the renin-angiotensin system within the kidney. The
findings that the renal tissue content of renin decreases from the
superficial to deep layers of the cortex and that renin release is
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higher in the superficial than in the deep cortical and medullary
nephrons (Peart, 1959a; Brown et al., 1966; Jones et al., 1979) suggests
that All may not be formed homogeneously throughout the kidney.
Significant amounts of renin activity have been found in the uterus
and placenta (Gross et al., 1964; Ferris et al., 1967; Anderson et al.,
1968; Carretero et al., 1971). The renin from these two tissues is
similar to renal renin (Anderson et al., 1968; Ryan and Johnson, 1969).
Both uterine and placental renin increase during pregnancy (Ferris et
al., 1967; Hodari et al. , 1969; Chesley, 1974). Although plasma renin
activity varies greatly during pregnancy in mammals, most human studies
show that plasma renin activity is increased during normal pregnancy
(Skinner et al., 1972; Weir et al., 1975). Plasma renin is also
increased at ovulation and during the luteal phase of the menstrual
cycle. However, it is not known how much of the increase in plasma
renin during the menstrual cycle and pregnancy is of uterine or
uteroplacental origin.
Renin-like activity was first discovered in the rat and dog brain
by Ganten et al., (1971) and independently by Fischer-Ferraro et al. ,
(1971). In 1976, Day and Reid raised the question of whether brain
renin was in fact Cathepsin D (an acid protease normally present in
lysosomes) and thus raised doubts about the physiological significance
of the reported brain renin. However, using affinity ion exchange
chromatography, Ganten and Speck, (1978), Hirose et al., (1978), Osman
et al., (1979), Inagami et al., (1980), independently showed that
Cathepsin D could be separated from brain renin and that the latter had
the ability to form Al at a neutral pH. Thus, it is now generally
accepted that there is a brain renin separate from the acid protease
Cathepsin D.
Since renin does not penetrate the blood-brain barrier and renin
activity persists in the brain after nephrectomy, it is likely that the
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enzyme is synthesised within the brain itself (Fischer-Ferraro et al.,
1971; Ganten et al., 1972). The concept of a renin generating system
within the brain is supported by several studies which demonstrated the
presence of renin (and other components of the renin-angiotensin system)
in neuroblastoma cells lines (Fishman et al., 1981; Inagami et al.,
1982) .
Werle et al. , (1957) reported extremely high concentrations of
renin-like activity in the submaxillary gland of the mouse. This enzyme
has been purified and reported to have a molecular weight of 42,000
(Werle et al., 1968; Cohen et al., 1972). Recently Misono et al.,
(1982) determined the complete amino acid sequence of mouse submaxillary
gland renin. They found that, of the amino acids, 43% were identical to
those in porcine pepsin. Although the physiological role of mouse
submaxillary gland renin is not known, it shares many characteristic
properties with mouse renal renin including immunological reactivity
(Michelakis et al., 1974).
Brown et al. , (1964a) failed to find sufficient renin activity in
the blood of hypertensive subjects to account for the elevation of blood
pressure. This led to the search for the enzyme in the blood vessel
wall. Indeed, renin activity has been found in the large arteries and
veins of the hog and dog (Dengler, 1956; Gould et al. , 1964). This
renin-like activity is similar to renal renin. Ganten et al., (1970)
found renin activity in the plasma of 24-hour nephrectomised dogs and
that this activity increased after haemorrhage. At the same time renin
activity in portal vein and splanchnic blood of such animals increased
at a faster rate than in arterial blood. From these findings they
concluded that the splanchnic bed has the capacity to synthesise and
secrete renin into the general circulation.
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PURIFICATION AND PROPERTIES OF RENIN
Various techniques have been employed to isolate renin from
kidneys. Studies in which acid conditions were used have resulted in
multiple proteins with renin-like activity (Skeggs et al., 1967). Using
gel filtration and ultracentrifugation techniques, Levine et al., (1970)
and Rubin (1972) showed that the molecular weight of the predominant
species of hog renal renin was 40,000. A major protein component
isolated by affinity chromatography of hog kidney was demonstrated to
have a molecular weight of 40,000 (Murakami and Inagami, 1975). In
addition, Waldhausl et al., (1970) reported a molecular weight of 42,000
for human renal renin. Recently, using improved gel filtration and
affinity chromatographic techniques, renal renins purified from hog,
dog, rat and human kidneys were found to have molecular weights of
approximately 40,000 (Corvol et al. , 1977; Inagami and Murakami, 1977;
Dzau et al., 1979; Galen et al., 1979; Yokosawa et al., 1980; Atlas et
al., 1981). These enzymes were found to have a broad pH optimum in the
pH 5.6 - 7.0 range when tested with homologous substrate, although both
higher and lower pH optima were observed with heterologous or synthetic
peptide substrates. Human kidney renin was found to have a somewhat
narrower pH optimum with homologous substrate at about pH 6 (Yokosawa et
al., 1980).
The molecular weight of human plasma renin as measured by gel
filtration has been reported to be approximately 50,000 (Takii et al. ,
1980; Atlas et al. 1981), which is somewhat higher than the molecular
weight of 40,000 reported for purified human renal renin (Inagami and
Murakami, 1977; Corvol et al. , 1977; Dzau et al., 1979; Galen et al.,
1979; Yokosawa et al., 1980; Atlas et al., 1981).
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INACTIVE RENIN
An inactive form of renin in human amniotic fluid was first
reported by Lumbers (1971). She showed that amniotic fluid dialysed to
a pH of 3.3 and then back to a pH of 7. A had a higher renin
concentration than amniotic fluid dialysed to a pH above A.O, and
suggested that this effect was due to activation of an inactive form of
renin by acid. Since then, there have been many reports of
high-molecular weight forms of renin with low enzymatic activity in
amniotic fluid, plasma and renal tissue. This new aspect of the renin
problem has acquired a degree of complexity which is reflected in the
nomenclature since the high-molecular weight forms of renin have been
given different names by different research groups, eg, "big renin" (Day
and Luetscher, 1974), "inactive renin" (Leckie and McConnell, 1975;
Skinner et al. , 1975) and "prorenin" (Sealey et al. , 1976). I do not
intend to review this subject and readers are referred to the following
comprehensive review articles (Inagami and Murakami, 1980; Sealey et
al., 1980;1983; Leckie, 1981).
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CONVERTING ENZYME
Renin cleaves the a2~globulin angiotensinogen to produce the deca-
peptide AI that is subsequently converted to the highly active octa-
peptide All by a peptidyl dipeptide hydrolase also know as angiotensin-
converting enzyme. Yang et al. , (1970) demonstrated that the dipeptide
hydrolase, kininase II, which inactivates the potent vasodepressor
peptides bradykinin and kallidin is the same enzyme as angiotensin-
converting enzyme.
OCCURRENCE OF THE ENZYME
Converting enzyme was first isolated from horse plasma by Skeggs et
al., (1954). The role of this enzyme was not appreciated until Helmer
(1955) using in vitro aortic strips, showed that AI was inactive until
exposed to plasma, whereas All was active without prior exposure to
plasma. Following the report by Ng and Vane (1967) that the conversion
of AI to All by the plasma enzyme was too slow to account for the very
rapid action of AI in vivo, it was established that the lungs contained
a high level of converting enzyme activity (Bakhle, 1968; Ng and Vane,
1968).
It has been found that in the lung, the surface of the vascular
endothelial cells is rich in enzyme (Bakhle, 1968; Ryan et al. , 1971;
1975; Smith et al., 1973; Ryan and Ryan, 1980), and that converting
enzyme is probably located on the pinocytotic vesicles of the
endothelial cells. These results together with the finding that there
was substantial conversion of AI during a single passage through the
lung (Bakhle et al., 1969; Aiken and Vane, 1970; Ryan et al., 1971;
Biron and Campeau, 1971; Igic et al., 1972), suggested that the lung was
the most important site for conversion of AI.
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However, converting enzyme has also been found in many different
tissues in several species (Roth et al., 1969; Cushman and Cheung, 1971
a; Horky et al., 1971; Poth et al. , 1975). For example, high enzyme
activity has been found in rat testicles (Cushman and Cheung, 1971 a),
rat lymph (Horky et al., 1971), human and rat brain (Yang and Neff,
1972; Poth et al., 1975) and rabbit liver, adrenal cortex, pancreas and
spleen (Caldwell et al., 1976).
Converting enzyme has also been reported in the kidney. Using
fluorescent immunohistochemistry, it was demonstrated that converting
enzyme was present in the endothelial cells of glomerular and
inter-glomerular capillaries and on the epithelial cells of the proximal
tubules of rabbit kidneys. Converting enzyme activity has been
localised in the brush border membrane from proximal tubules in the
kidney (Ward et al., 1977; Caldwell et al., 1976; Ryan et al., 1976;
Takada et al. , 1982). More recently, using improved immunocytochemical
methods, converting enzyme was found in specific endothelial cells in
the rat kidney (Taugner et al. , 1982a). Enzyme activity was found in
the endothelial cells of all kidney arteries, the afferent and efferent
arterioles, some glomerular capillaries and the first branches of the
peritubular capillaries, although no activity was observed in renal
veins or renin producing granulated cells (Taugner et al., 1982a). The
presence of converting enzyme activity in the kidney has also been
demonstrated by the conversion of Al to All during passage through the
kidney, with estimates of the magnitude of this conversion ranging from
1 to 20% (Ng and Vane, 1968; Franklin et al. , 1970; Di Salvo et al. ,
1971; Hofbauer et al., 1976; Britton, 1981). Recently Rosivall et al.,
(1983) reported that mean conversion of Al to All during a single
passage through the kidney was about 22% and that this did not change
under conditions in which renin secretion and Al generation rate
increased. All these results support the concept that All is formed not
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only systemically, but also intrarenally from blood borne and/or
intrarenally generated AI.
PURIFICATION AND PROPERTIES OF THE ENZYME
Converting enzyme has been purified from plasma, lung and kidney
from several species including human, guinea pig, hog, rabbit, calf and
rat (Lee et al., 1971; Eliseeva et al., 1971; Cushman and Cheung, 1972;
Dorer et al., 1972; Fitz and Overturf, 1972; Igic et al., 1972; Stevens
et al., 1972; Nakajima et al., 1973; Oshima et al., 1974; 1976; Das and
Soffer, 1975). The molecular weights found for the enzyme isolated from
rabbit serum, human and hog plasma, human, hog, guinea pig, calf and rat
lungs range between 140,000 and 480,000 (Lee et al., 1971; Dorer et al.,
1972; Fitz and Overturf, 1972; Stevens et al., 1972; Lanzillo and
Fanburg, 1974; 1976; Oshima et al. , 1974; Nishimura et al., 1976; 1978;
Das et al., 1977). The enzyme from the rabbit lung was found to be a
glycoprotein of molecular weight 129,000 consisting of a single
polypeptide chain, a polysaccharide residue accounting for 26% of the
dry weight, and one zinc atom per molecule (Soffer et al., 1974; Das and
Soffer, 1975). The enzymes isolated from rabbit serum, guinea pig and
human plasma, guinea pig and human lung and hog kidney were also found
to be glycoproteins and to contain zinc (Oshima et al. , 1974; 1976;
Lanzillo and Fanburg, 1976; 1977; Das et al. , 1977; Nishimura et al. ,
1978) .
Converting enzyme is a nonspecific dipeptidylcarboxypeptidase which
will cleave a wide variety of peptides including AI, bradykinin and
leu-&-met enkephalin by removing dipeptide fragments from the
carboxyl-terminal (Igic et al., 1972; Erdos, 1975; Skeggs et al., 1976).
There are several general requirements for catalytic activity. The
carboxyl terminal residue must be an L - amino acid with a free carboxyl
function. An acidic amino acid at the carboxyl-terminus reduces the
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susceptibility of the substrate to hydrolysis (Orekhovich, 1968). The
enzyme does not cleave a peptide that has a penultimate proline residue,
and hence converting enzyme does not cleave All (Ackerly and Peach,
1975).
Although the enzyme hydrolyses molecules as small as tripeptides
(Erdos, 1975), only (des-Asp^) AI among the carboxyl-terminal homologues
of AI, lb a physiological substrate tor converting enzyme (Chiu et al.,
1976; Tsai et al., 1975).
The rates of hydrolysis of various peptide substrates by converting
enzyme are markedly affected by the presence of monovalent anions such
as chloride (Cushman and Cheung, 1971b; Erdos, 1975; Cushman et al. ,
1978). For example, the hydrolysis of AI stops entirely in chloride
free medium whereas that of bradykinin continues at about 35-50% of the
optimum rate (Igic et al., 1973; Dorer et al., 1974). Chloride has been
described as an allosteric modifier of converting enzyme and chloride
ions lower the Km of the enzyme for substrate (Cheung and Cushman, 1973;
Oshima et al., 1974).
INHIBITORS
Converting enzyme is a metalloenzyme inhibited by metal complexing
agents such as EDTA, EGTA and dimercaptopropanol and by cations such as
2+ 2+ 2+ 2+ 2+
Ni ,Cd ,Hg ,Pb and Cu , that may serve to replace the zinc ions of
the enzyme to form a catalytically ineffective metalloenzyme (Huggins et
al., 1970; Cushman and Cheung, 1971b; Dorer et al. , 1976). Inhibition
2+ 2+ 2+
by chelators can be reversed by the addition of Co ,Ca or Mn
Converting enzyme is also inhibited to varying degrees by peptides that
may bind to the enzyme in the same manner as substrate or the
polypeptide or dipeptide products of the enzyme's action (Erdos, 1975;
Massey and Fessler, 1976; Tsai and Peach, 1977; Cushman et al., 1978).
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For example, products of the hydrolysis of AI and (des - Asp*) AI, such
as the dipeptide His - Leu; the heptapeptide fragment from the
hydrolysis of (des - Asp*) AI (AII1) and the hexa- and heptapeptides of
All inhibit converting enzyme (Tsai et al., 1975; Chiu et al., 1976;
Tsai and Peach, 1977; Cushman et al., 1978).
It was discovered that the venom of the Brazilian 'arrowhead' viper
B0THR0PS jararaca contained an active peptide fraction that potentiated
the in vitro action of bradykinin (Ferreira, 1965; Ferreira and Rocha e
Silva, 1965). The active peptide fraction which was called 'Bradykinin
- potentiating factor' or BPF was later shown to augment in vivo the
cardiovascular, CNS and antinociceptive actions of bradykinin (Ferreira,
1965; Ferreira and Rocha e Silva, 1965; Graeff et al., 1965; Amorim et
al., 1967; Ribeiro et al., 1971). Similar BPF fractions were isolated
from other B0THR0PS species and from the Japanese viper AGKISTR0D0N
halys blomhoffi (Ferreira, 1965; 1966). In 1968, Bakhle reported that
BPF inhibited angiotensin converting enzyme activity of dog lung
homogenate. This was followed by the finding that BPF inhibited
conversion of AI to All in the perfused guinea pig lung and in rats in
vivo (Bakhle et al., 1969; Ng and Vane, 1970). A number of the
component peptides from both BOTHROPS and AGKISTRODON venoms have been
isolated, sequenced and synthesised (Greene et al., 1969; Ferreira et
al., 1970; Kato and Suzuki, 1971; Ondetti et al., 1971; Stewart et al.,
1971; Cheung and Cushman, 1973).
Of those peptides, the first to be synthesised was the pentapeptide
BPF (Stewart et al., 1971), which was found to be a good inhibitor in
_) s
vitro and also a substrate of the enzyme (Aiken and Vane, 1970; Cushman
and Cheung, 1971b; Yang et al. , 1971; Cheung and Cushman, 1973). The
nonapeptide SQ 20,881 (BPF^, teprotide) and the undecapeptide 'Potent¬
iator C', also inhibit the enzyme but also contain a carboxyl-terminal
Pro-Pro dipeptide that is not cleaved by converting enzyme. Thus, they
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inhibit the hydrolysis of bradykinin and AI as competitive reversible
inhibitors without being substrates of the enzyme themselves (Igic et
al., 1972; Cheung and Cushman, 1973). Thus, peptide inhibitors can
either be a substrate for converting enzyme (as with BPF^ ) or not (asJ cL
with SQ 20,881).
The nonapeptide SQ 20,881 and other peptide inhibitors have been
used in humans and animals to explore the importance of the functions of
the renin-angiotensin system under a variety of conditions.
The recently discovered orally active inhibitor of converting
enzyme, captopril (D-3-mercapto-2-methylpropanoyl-L-proline; SQ 14,225),
has been used in the diagnosis and therapy of several forms of human
hypertension (Ondetti et al., 1977; Gavras et al., 1978; Rubin et al. ,
1978; Brunner et al., 1979). However, several serious side-effects
including maculopapillary rash, glomerulonephritis, proteinuria and
neutropenia were associated with the drug (Heel et al., 1980; Alexander
and Meyer, 1981). These side-effects were attributed to the sulphydryl
moiety of the drug (Heel et al., 1980). This has led to the development
of orally effective non-sulphydryl converting enzyme inhibitors.
Recently the diacids MK 421 and SCH 31846 have been described. Both
belong to the class of carboxyalkyldipeptide non-sulphydryl converting
enzyme inhibitors (Patchett et al. , 1980; Gross et al., 1981; Sweet et
al., 1981; Baum et al., 1983; Sybertz et al., 1983).
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ANGIOTENSINASES
Angiotensinases are peptides or proteolytic enzymes that catalyse
the hydrolysis of peptide bonds in All. Three general types of
angiotensinase activity have been described: aminopeptidase, acting on
the NH^-terminal end of the molecule (Glenner et al. , 1962; Khairallah
et al. , 1963; Khairallah and Page, 1967; Nagatsu et al., 1970);
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endopeptidase, acting on the tyrosine - isoleucine bond to form two
tetrapeptides (Khairallah et al., 1963; Regoli et al. , 1963; Matsunaga
and Masson, 1970) and carboxypeptidase, acting on the COOH-terminal end
of the All molecule (Johnson and Ryan, 1968; Yang et al., 1968;
Matsunaga and Masson, 1970).
AMINOPEPTIDASES
Glenner et al., (1962) first identified aminopeptidase activity in
a microsomal preparation from rat kidney homogenates. Two All degrading
enzymes were then found in plasma (Khairallah et al. , 1963; Nagatsu et
al., 1970), and called angiotensinase A^, and angiotensinase A0.
Angiotensinase A^ was found to be an aminopeptidase selective for an
NE^- terminal asparaginyl residue, was inhibited by EDTA, had a pH
optimum of 7.4 and was stable at 60°C for 30 minutes (Khairallah and
Page, 1967). Angiotensinase A^ however, was found to be an
aminopeptidase selective for an N^-terminal aspartyl residue. This
enzyme was also inhibited by EDTA, had a pH optimum of 6.8 and was heat
labile (Khairallah and Page, 1967).
Khairallah et al., (1963) identified an aminopeptidase in red blood
cells that seemed to correspond to plasma angiotensinase. Both were
2+ 2+
found to be inhibited by epsilon aminocaproic acid, Hg and Cd
(Itskovitz and Miller, 1967). The significant type of angiotensinase
activity reported in red blood cells, aminopeptidase, was reported to be
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confined to the inside of the red blood cell membrane (Moore et al. ,
1977). However, the functional role of this enzyme is still not known
since it is unclear whether or not the red cell enzyme has access to
circulating All.
Aminopeptidase activity has been reported in the proximal tubules
and juxtaglomerular apparatus (JG) of the kidney. This activity, which
is present in the microsomal fraction, has a neutral pH optimum and
2+
requires Ca (Hess, 1965; Itskovitz and Miller, 1966; Granger et al.,
1969; Pullman et al., 1975). However, since this enzyme was found not
to hydrolyse (des - Asp^) Al, while the isolated perfused kidney and
kidney in vivo does degrade this nonapeptide, it is unlikely that this
enzyme is physiologically the most important aminopeptidase (Leary and
Ledingham, 1970b; Cheung and Cushman, 1971; Oparil et al. , 1971; Oparil
and Bailie, 1973; Misumi et al., 1983).
Aminopeptidase activity has been reported in brain homogenates,
intestine, spleen, adrenal, pancreas, lung and vascular tissue
(Itskovitz and Miller, 1967; Abrash et al. , 1971; Ledingham and Leary,
1974; Palaic and Farrugia, 1980). It is difficult to assign any
physiological importance to many of these aminopeptidases. For example,
although lung homogenates rapidly degrade All, very little All, if any,
is degraded in the intact lung (Itskovitz and Miller, 1967; Leary and
Ledingham, 1969). However, the vascular response to angiotensin can be
enhanced by using angiotensinase inhibitors, the membrane bound
angiotensin in vascular tissue shows identical binding properties for
All as angiotensin receptors, and the aminopeptidase on the outside of
adrenal cells catalyses the conversion of All to AIII. These findings
suggest that the tissue bound aminopeptidases in vascular and adrenal
cells may be important in angiotensin receptor operation and regulation,
and for All induced aldosterone secretion (Blair-West et al., 1971a;
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Campbell et al., 1974; Peach and Chiu, 1974; Goodfriend and Peach, 1975;
Le Morvan et al., 1977; Moore et al., 1977; Farruggia et al., 1979).
ENDOPEPTIDASES (MGIOTENSINASE B)
In 1963, Regoli et al., isolated from plasma kidney homogenates an
endopeptidase that was active at at acidic pH and degraded All into two
tetrapeptides. Khairallah and Page (1967) identified an enzyme from
plasma which hydrolysed analogues of All that were resistant to
aminopeptidase hydrolysis. This enzyme was inhibited by
dlisopropylphosphofluoridate (DFP) and it was suggested that this was an
acid endopeptidase and was labelled "angiotensinase B".
McDonald et al., (1974) isolated an enzyme in the lysosomal
fraction of rat liver which hydrolysed All. This enzyme had a pH optium
of 5.0 and had a greater hydrolytic activity on peptides with
penultimate basic residues. This enzyme was found to be a
dipeptidylaminopeptidase (Cathepsin C).
CARBOXYPEPTIDASES (ANGIOTENSINASE C)
Yang et al., (1968) first obtained a carboxypeptidase capable of
hydrolysing All from urine. This enzyme (soluble) of renal origin was
stable at 60°C, was inhibited by DFP and released phenylalanine from
All. This enzyme was originally named "angiotensinase C", and has now
been characterised as a prolylcarboxypeptidase specific for the
hydrolysis of COOH-terminal amino acids with a penultimate prolyl
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residue and splits the -Pro - Phe bond of All (Kakimoto et al., 1973).
This enzyme has been found in the lysosomes of the kidney and spleen.
This enzyme was purified from kidney cortex and was found to have a
molecular weight of 210,000 (Kakimoto et al. , 1973). It is doubtful
whether this heat stable enzyme accounts for much of the total angioten¬
sinase activity in the kidney, since Johnson and Ryan (1968) showed that
over 90% of the total renal activity was inactivated by heating at 56°C
for 30 minutes. Johnson and Ryan (1968) also found evidence of carboxy-
peptidase activity in aqueous extracts of rabbit liver. This enzyme
accounted for 30% of hepatic angiotensinase activity. It is similar to
prolylcarboxypeptidase in that it is active at acid pH, is heat stable
and is inhibited by DFP.
Goldstein et al., (1972) isolated a carboxypeptidase from brain
tissue of rat and dog. However, this enzyme differs from the
prolylcarboxypeptidase in that it was found to degrade AI and All,
whereas the prolylcarboxypeptidases do not cleave AI.
HALF-LIFE OF ANGIOTENSIN II
The half-life of All in vivo is approximately one minute in the
human and in the order of 20 - 30 seconds in the rat, and most
disappears during a single passage through the vascular beds of various
regions and organs in the systemic circulation (Hodge et al., 1967;
Biron et al. , 1968; Doyle et al., 1968; Leary and Ledingham, 1969;
Ledingham and Leary, 1974; Ryan, 1974; Al-Merani et al., 1978; Brooks et
al. , 1983). The half-life of All in vivo is substantially shorter than
that in whole blood or plasma in vitro. These findings suggest that in
vivo, All is hydrolysed primarily by tissue angiotensinases (Biron et
al., 1968; Ng and Vane, 1968; Leary and Ledingham, 1969; Osborne et al.,
1970; Oparil and Bailie, 1973; Regoli et al., 1974; Ryan, 1974).
MODULATION OF ANGIOTENSIN METABOLISM
It has been suggested that the modulation of the rate of angio¬
tensin metabolism is involved in the control of circulatory All levels
(Blair-West, 1976). Alterations in sodium balance have been reported to
alter angiotensin metabolism, although the results of different workers
do not agree. Lubash et al., (1971) and Johnston et al., (1972) found
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that sodium depletion altered angiotensin metabolism in man while Nast
et al., (1975) observed no change. Leary and Ledingham (1970a; 1970b)
found that the capacity of the kidney, but not the liver, to catabolise
All was reduced by sodium loading, and enhanced by sodium depletion.
However, Hollenberg et al., (1974) and more recently, Brooks et al.,
(1983) observed that the half-life of All in the circulation was
unaltered during sodium loading or restriction, and concluded that
differences in sodium balance have no effect on the disappearance of All
from the circulation.
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INTRARENAL LOCALISATION OF COMPONENTS
OF THE RENIN-ANGIOTENSIN SYSTEM
As discussed in the previous sections, renin substrate, renin and
converting enzyme have been localised within the kidney. Bailie et al.,
(1971) observed that All concentrations in dog lymph were over 100 times
greater than in plasma. Similarly, Mendelsohn (1976; 1979) found that
All immunoreactive material was present in rat kidney in concentrations
which greatly exceeded that which could be accounted for by trapped
blood. More recently using immunohistochemistry, Taugner and co-workers
found renin-like and All-like immunoreactivity to co-exist within the
granulated epithelial cells of the afferent arterioles in rat kidney
(Taugner et al. , 1982a;1982b;1982c; 1983). In addition, Rightsel, et
al., (1982) reported that a monolayer cell culture of juxtaglomerular
cells contains immunoreactivity of renin, converting enzyme and
angiotensins I, II and III. Together, these findings support the
concept of All generation by an intrarenal renin- angiotensin system
(Thurau and Mason, 1974; Taugner et al., 1982a; 1982b). The question as
to whether intrarenally formed All is synthesised within the granulated
epithelial cells (Celio and Inagami, 1981) or in the extracellular space
and subsequently taken up by endocytosis (Taugner and Hackenthal, 1981)
remains to be clarified.
It is unlikely that the Al released from the juxtaglomerular cells
directly into the lumen of the terminal portion of the afferent
arteriole could exert a significant effect on afferent arterioles via
the intra-renal formation of All, although recirculated angiotensin
could act on the afferent arterioles. However, All released into the
lumen of the afferent arteriole could pass through the glomerulus,
efferent arterioles and peritubular capillaries and thus exert its
effect on these structures (Mendelsohn, 1979). Alternatively, ATI could
exert its influences on the afferent and efferent arterioles and
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glomerular and peritubular capillaries if it was formed in the
surrounding interstitial space (Thurau, 1974; Morgan and Davis, 1975;
Morgan and Gillies, 1977). In addition, the molecular weights of AI and
All would allow their filtration through the glomerular membrane and
into the proximal tubule. Converting enzyme has been shown to be
present in the brush border of proximal tubular cells (Takada et al.,
1982), while specific binding sites for All have been found in renal
brush border membranes (Brown and Douglas, 1982).
Although it is now generally accepted that All can be formed both
intrarenally and at extrarenal sites and that this agent can serve as a
circulating vasoactive substance or as an intrarenal hormone, the
relative importance of these routes of angiotensin formation in the
regulation of renal function remains to be clarified.
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EFFECTS OF ANGIOTENSIN II ON RENAL FUNCTION
The renal actions of All as a circulating hormone have been
assessed by evaluating the responses to systemic or intra-arterial
infusions of the peptide, whereas the role of All as an intrarenal
hormone has been investigated by the inhibition of the formation of
endogenous All with converting enzyme inhibitors (ie, teprotide and
captopril) or by using All receptor antagonists (ie, saralasin).
EFFECTS OF All ON URINARY SODIUM AND WATER EXCRETION
Intravenous infusion of angiotensin elicits dose-dependent effects
on urinary sodium and water excretion in man, rabbit, dog, monkey and
rat (Navar and Langford, 1974). Infusion of low sub-pressor doses (1-50
ng.kg ^.min *) elicits a decrease in urine flow rate and urinary sodium
excretion (Barraclough, 1965; Louis and Doyle, 1965; Barraclough et al.,
1967; Malvin and Vander, 1967; Bonjour and Malvin, 1969; Johnson and
Malvin, 1977).
Most investigators have attributed the observed antinatriuresis and
antidiuresis to the associated marked decrease in renal blood flow (RBF)
and lesser fall in glomerular filtration rate (GFR) (Bock et al., 1958;
Peart, 1959b; De Bono et al., 1963; Louis and Doyle, 1965; Malvin and
Vander, 1967; Bonjour and Malvin, 1969). Infusion of pressor doses of
All causes a transient decrease in urinary sodium excretion and urine
flow rate followed by a marked natriuresis and diuresis (Barraclough,
1965; Healy et al., 1965; Barraclough et al., 1967; Malvin and Vander,
1967; Bonjour and Malvin, 1969; Healy and Elliott, 1971). The initial
phase of the response to pressor doses of All may be explained, as can
the response to low doses, by the concomitant decrease in RBF and GFR.
However, the mechanism responsible for the natriuretic phase of the
response is still not clear. Several groups reported that the natriu-
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retic response was not related to the pressor response and that the
maximum natriuretic response occurred after blood pressure had fallen
some way towards control level (Villarreal et al. , 1964; Louis and
Doyle, 1965). Healy and Elliott, (1971) showed that the natriuretic
response in rabbits still occurred even when the increase in blood
pressure was prevented by haemorrhage, and postulated that a direct
inhibitory effect on tubular reabsorption by angiotensin was responsible
for the natriuresis.
Although the response to infusion of low doses of All has been
explained by the secondary changes in haemodynamics, Barraclough et al.,
(1967) and Johnson and Malvin (1977) showed that the antinatriuretic
response to infusion of a low dose of angiotensin was independent of
changes in GFR, and suggested that angiotensin in small doses
facilitates tubular sodium reasorption.
Barraclough et al., (1967) reported that the antinatriuretic
response to low doses of All in conscious rats was observed only when
the animals had been chronically sodium loaded and that sodium depletion
abolished or even converted the antinatriuretic effect of angiotensin to
a natriuretic one. They suggested that in its normal state, the rat
produces almost optimal antinatriuretic amounts of angiotensin in order
to maintain sodium homeostasis and that it is necessary to sodium load
the animal to suppress endogenous angiotensin production, in order to
demonstrate an antinatriuretic effect of the infused hormone.
HAEMODYNAMIC EFFECTS
There is controversy regarding the major site at which All
regulates renal haemodynamics. Clearance studies in both intact animals
and isolated perfused kidneys have demonstrated that All elicits
dose-dependent decreases in RBF and proportionately smaller decreases in
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GFR such that filtration fraction increases (Navar and Langford, 1974;
Davalos et al., 1978; Lohmeier and Cowley, 1979; Krahe et al., 1981;
Rosivall and Navar, 1983). Because of the greater reductions in RBF
than GFR it has been suggested that All exerts a preferential effect on
the efferent arterioles (Levens et al., 1981a; Hall, 1982). However,
this is not necessarily the only explanation since increases in
filtration fraction can occur even with balanced increases in pre- and
postglomerular resistances (Rosivall and Navar, 1983). In micropuncture
studies it has been observed that systemic or renal artery infusions of
All increase both afferent and efferent arteriolar resistances (Myers et
al., 1975; Blantz et al., 1976; Rosivall and Navar, 1983). Further,
Click et al., (1979) demonstrated that in the hamster renal transplant
preparation both afferent and efferent arterioles responded directly to
All although the effects of the peptide appeared to be slightly greater
on the efferent arteriole. These data indicate that All exerts
vasoconstrictor actions on both pre- and postglomerular resistance
vessels.
It is possible that some of these effects on the afferent arteriole
were not the result of the direct effects of the hormone but were
indirect effects due to activation of other intrinsic autoregulatory
mechanisms such as myogenic or tubuloglomerular feedback control. For
example, Myers et al. , (1975) found that although All infusion raised
both afferent and efferent arteriolar resistances, when the renal
perfusion pressure was kept constant, the increase in the afferent but
not the efferent resistance was almost abolished. Ichikawa et al. ,
(1979) observed that only the efferent arteriolar resistance increased
when All was infused directly into the renal artery. More recently,
Hall and Granger, (1983) found that when endogenous All formation was
blocked by captopril infusion and renal perfusion pressure was held
constant, infusion of All caused no changes in GFR, but reduced renal
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blood flow and increased both pre- and postglomerular resistance.
However, when glomerular filtration was stopped by ureteral occlusion,
no change in preglomerular resistance was observed during infusion of
All. In a study using isolated rabbit renal microvessels, it was
-12
demonstrated that the efferent arteriole responded to All (10 to
—8
10 M) whereas the interlobular artery and afferent arteriole did not
(Edwards, 1983). These results were interpreted as providing support
for the concept that the primary site of action of All is on the
efferent arteriole.
However it is possible that the apparent lack of responsiveness of
the preglomerular vessels to All observed under some conditions is due
to the counteracting effects of vasodilator prostaglandins. Indeed,
Baylis and Brenner (1978) reported that the effects of All, in parti¬
cular on preglomerular resistance, were much more pronounced during
inhibition of prostaglandin synthesis. These results are consistent
with the findings that All can stimulate intrarenal production of
vasodilator prostaglandins (Brenner et al., 1980; McGiff, 1980; Schor et
al., 1980; Baer, 1981), which, in turn, may help protect the renal
circulation from the vasoconstrictor effects of All. Thus, the actual
resistance alterations observed in response to All may be determined by
the relative status of the intrarenal prostaglandin system.
EFFECTS ON Kf
In addition to it's reported actions on renal vascular resistance,
All has been reported to decrease the glomerular capillary ultra¬
filtration coefficient (Kf) (Myers et al., 1975; Blantz et al. , 1976).
More recently it was found that the Kf-reducing effects of other
vasoactive hormones including prostaglandin E^, prostacyclin and
parathyroid hormone were abolished by the competitive All antagonist,
saralasin, suggesting that these substances exert their effects on Kf
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via an increase in AIT activity (Schor et al. , 1981). These vasoactive
hormones have also been shown to enhance cyclic nucleotide production
(cAMP and/or cGMP) in mammals (Dousa et al., 1980). In addition, cAMP
has been shown to be capable of stimulating renal renin release and thus
All production (Okahara et al., 1977; Hofbauer et al., 1978; Campbell et
al., 1979; Freeman et al., 1984). Therefore, it has been suggested that
these vasoactive hormones decrease Kf by virtue of their ability to
stimulate renal renin release and thus All production via the generation
of cAMP, the resulting increase in local glomerular All concentration
causing mesangial cell contraction and a fall in Kf (Schor et al., 1981;
Dworkin et al., 1983).
All has been reported to decrease Kf in a variety of physiological
conditions, including chronic sodium depletion (Steiner et al. , 1979;
Schor et al., 1980; Tucker and Blantz, 1983), chronic elevations in
ureteral pressure (Ichikawa and Brenner, 1979), aortic constriction with
reductions in renal artery pressure (Ichikawa and Brenner, 1980) and
acute renal denervation (Pelayo and Blantz, 1984). These results
suggest that All influences glomerular function by directly modulating
glomerular capillary ultrafiltration as well as by controlling pre- and
postglomerular resistances. Although All has been shown to contract
mesangial cells in culture as well as glomeruli in vivo and in vitro,
the exact mechanism whereby All decreases Kf is not known (Hornych et
al., 1972; Sraer et al., 1974; Hornych and Richet, 1977; Ausiello et
al., 1980; Foidart et al., 1980; Mahieu et al., 1980).
EFFECTS ON THE PERITUBULAR CAPILLARIES
In microperfusion studies, it was demonstrated that All infused
directly into the peritubular capillaries contracted the capillaries and
increased peritubular capillary and proximal tubular hydrostatic
pressures (Jensen and Steven, 1977; Steven and Thorpe, 1977). These data
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therefore indicate that All may influence peritubular capillary dynamics
through a direct effect on peritubular capillary structures.
EFFECTS ON INTRARENAL DISTRIBUTION OF BLOOD FLOW
The effects of All on the regional distribution of RBF are
controversial due to the different responses observed with different
methods. Using the inert gas-washout technique, Carriere and Friborg
(1969) and Rentsch et al. , (1976) reported that All was capable of
causing a preferential decrease in cortical blood flow while maintaining
or increasing relative blood flow through the deep juxtamedullary
nephrons. It was suggested that this could explain the antidiuretic
effect of angiotensin. However, using the hydrogen washout technique,
Aukland, (1968) had previously found that angiotensin failed to produce
a redistribution of renal blood flow, even when a wide range of doses
were employed. Using radiolabelled microspheres, Rector et al., (1972)
found that angiotensin infusions produced a parallel decrease in renal
blood flow in each zone. Itskovitz and McGiff, (1974) observed a
reduction in inner cortical microsphere distribution during All
infusions in isolated perfused dog kidneys, although this was found only
to occur after prostaglandin production has been stopped with indometha-
cin. More recently Britton (1981) reported that renal artery infusion
of both Al and All produced greater decreases in inner cortical blood
flow than outer cortical flow as determined by the distribution of
radioactive microspheres. The differences between the results of these
studies may be related to the dose or duration of infusion of All
employed in each study. Despite the different responses observed with
different flow measurement methods, it can be concluded that all regions
of the renal vasculature respond to exogenous All, but subtle
quantitative differences in regional sensitivity may exist.
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EFFECTS ON RENIN RELEASE
Infusion of All inhibits renal renin release (Vander and Geelhoed,
1965; Blair-West et al. , 1971b; Shade et al. , 1973; Davis and Freeman,
1976). Blair-West et al., (1971b) reported that physiological levels of
All acted directly on the kidney to decrease renin secretion in sheep
and that the response was independent of changes in renal arterial
pressure and sodium excretion. Shade et al., (1973) observed a decrease
in renin secretion when small physiological amounts of All were infused
into the renal artery of a non-filtering kidney preparation. It has
been observed that angiotensin decreases renin release in the absence of
changes in sodium excretion rate and of a functional macula densa, in a
non-filtering isolated perfused kidney preparation (Vandongen and Peart,
1974). Also, using the rat renal cortical slice preparation, Naftilan
and Oparil have shown that All inhibits renin release in a dose dependent
manner via a direct action on the juxtaglomerular cells (Naftilan and
Oparil, 1978; 1981; 1982). This negative feedback effect of All on
renal renin release appears to be dependent upon the presence of external
calcium (Vandongen and Peart, 1974; Churchill, 1980; Naftilan and Oparil,
1982) .
EFFECTS OF BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM ON RENAL
HAEMODYNAMIC S
Pharmacological inhibitors or antagonists that block the formation
or action of All have been used to evaluate the intrarenal effects of
All. The responses observed with these blockers depend to a large
extent on the pre-existing level of activity of the renin-angiotensin
system (Regoli et al., 1974; Kimbrough et al., 1977; Fagard et al.,
1978; Hollenberg, 1979; 1982; Wong and Zimmerman, 1982). In animals in
which the activity of the renin-angiotensin system is normal or enhanced
by dietary sodium restriction, angiotensin blockade is associated with a
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small decrease in arterial blood pressure and marked increases in RBF
and water and electrolyte excretion (Hall et al. , 1977b; Kimbrough et
al., 1977; Lohmeier et al., 1977; Fagard et al., 1978; Hollenberg, 1979;
Navar et al. , 1979; 1982; Ploth et al., 1979; Plotb and Roy, 1982a;
Carmines et al., 1983). However, the effects on GFR have been less
consistent; some studies have shown small increases (Kimbrough et al.,
1977; Lohmeier et al., 1977; Ploth et al. , 1979; Navar et al., 1982;
Ploth and Roy, 1982a; Carmines et al., 1983) whereas others have failed
to demonstrate significant changes (Fagard et al. , 1978; Clappison et
al., 1981).
Because the GFR responses to angiotensin blockade are less
consistent and smaller in magnitude than the RBF responses, the data
have been interpreted as indicating that All exerts a preferential
effect on the efferent arterioles (Hall et al. , 1977b; 1977c; Johns,
1980; Levens et al., 1981a; Hall, 1982). In addition it has been
suggested that intrarenally formed All helps to maintain efferent
arteriolar tone, particularly when renin secretion rate is high, such as
during sodium restriction or reduced renal perfusion pressure (Hall et
al., 1977c; Johns, 1980; Hall, 1982). This is based on the finding that
GFR autoregulation, but not RBF autoregulation, is markedly attenuated
in sodium-restricted animals infused with angiotensin blockers and in
renin-depleted dogs (Hall et al. , 1977a; 1977c; Johns, 1980; Hall,
1982). However, other studies have failed to demonstrate an impairment
of GFR or RBF autoregulatory capability during infusions of angiotensin
blockers (Gagnon et al., 1974; Anderson et al., 1975; Kaloyanides and Di
Bona, 1976; Navar et al. , 1982).
Navar et al. , (1982) demonstrated that infusion of captopril in
sodium-restricted dogs caused significant increases in RBF and GFR and a
significant decrease in filtration fraction. Using micropuncture
techniques they found that when renal perfusion pressure was kept
37
constant, captopril induced approximately equivalent decreases in
afferent and efferent arteriolar resistances. Using sodium-restricted
rats, Steiner et al., (1979) observed that administration of the All
antagonist saralasin caused an increase in single nephron glomerular
filtration rate (SNGFR) and glomerular plasma flow and resulted in
significant decreases in preglomerular resistance. Further, Ploth et
al., (1979) reported that infusion of teprotide in hydropenic rats
caused a significant increase in SNGFR. Therefore, the data from
micropuncture studies utilising blockers of the renin-angiotensin system
are consistent with the concept that the vasoconstrictor action of All
is exerted approximately equally by pre- and postglomerular vessels and
do not support the notion that All exerts a preferential effect on the
efferent arteriole.
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THE ROLE OF ANGIOTENSIN II IN THE
TUBULOGLOMERULAR FEEDBACK MECHANISM
The tubuloglomerular feedback mechanism is responsive to flow
related changes in distal tubular fluid composition such that increases
in distal flow rate lead to increases in afferent arteriolar resistance
and decreases in SNGFR (Guyton et al. , 1964; Thurau, 1964; Wright and
Briggs, 1979; Briggs and Wright, 1979; Navar et al. , 1980; 1981; Bell
and Navar, 1982; Schnermann, 1981). This mechanism operates at the
single-nephron level and exerts a major controlling influence on GFR
(Briggs and Wright, 1979; Wright and Briggs, 1979; Navar et al. , 1980;
1981; Schnermann, 1981; Bell and Navar, 1982). The tubuloglomerular
feedback mechanism is distinct from the phenomenon of glomerulotubular
balance (GTB). GTB is defined as the ability of each successive segment
of the proximal tubule to reabsorb a constant fraction of glomerular
filtrate and solutes delivered to it. For a more detailed account of
glomerulotubular balance the reader is referred to the following
comprehensive review articles (Gertz and Boylan, 1973; Steven, 1977;
Kiil, 1982; Haberle and Von Baeyer, 1983).
Thurau and co-workers postulated that increased concentrations of
sodium chloride delivered to the macula densa area of the distal tubule
result in increased local renin activation or release which in turn
results in increased formation of All and afferent arteriolar
constriction (Thurau and Mason, 1974; Thurau, 1974; 1981; Thurau et al.,
1982). This proposal that increased formation of All is the mediator of
feedback-induced changes in afferent arteriolar resistance and GFR is
however at variance with the finding that increased renin release is
associated with decreases in distal sodium chloride concentration
(Vander, 1967; Davis and Freeman, 1976; Churchill et al. , 1978). In
addition, it has been demonstrated that most manipulations that increase
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renin release such as sodium depletion, increased activity of
sympathetic nervous system or reductions in arterial pressure are
associated with decreases in distal sodium chloride concentration
(Vander, 1967; Davis, 1973; Davis and Freeman, 1976). Furthermore,
Muller-Suur et al. , (1975) reported that in animals subjected to a wide
variety of manoeuvres designed to alter intrarenal renin contents,
feedback activity did not correlate with the measured renal renin
contents directly. These data are therefore not consistent with the
hypothesis that increased local formation of All mediates the feedback
responses to increases in distal flow rate.
It has been shown that pharmacological blockade of the
renin-angiotensin system attenuates but does not abolish
tubuloglomerular feedback activity (Ploth et al., 1979; Stowe et al.,
1979; Ploth and Roy, 1982b). In addition, infusion of All during
converting enzyme blockade results in partial restoration of feedback
activity (Ploth and Roy, 1982b). These results are consistent with the
hypothesis that All acts to modulate the sensitivity of the feedback
mechanism rather than directly mediate the feedback-induced afferent
arteriolar constriction (Navar et al., 1980; Bell and Navar, 1982; Ploth
and Roy, 1982b).
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EFFECTS OF ANGIOTENSIN III ON RENAL FUNCTION
Freeman et al., (1975) investigated the effects of intrarenal
infusion of both All and (des - 1 - Asp) All (AIII) on renal function in
normal and sodium-depleted dogs. In sodium-replete dogs, both peptides
caused comparable reductions in RBF and renin secretion although no
change in arterial pressure, creatinine clearance or sodium excretion
was observed with either peptide. In sodium-depleted dogs, although
both All and AIII reduced renin secretion, neither peptide significantly
altered RBF, GFR, blood pressure or sodium excretion, suggesting that
AIII, like All inhibits renal renin release.
Although it has been reported that AIII has only 25 - 50% of the
pressor activity of All, Freeman et al., (1975) and Caldicott et al. ,
(1981) reported that All and AIII were nearly equi-potent on the renal
vasculature. However, Taub, et al., (1977) and Satoh et al., (1981)
reported that in the dog, All had a greater effect on the renal
vasculature than AIII. Similarly, Hall et al., (1979a) found that
1 8
intrarenal infusion of the heptapeptide antagonist (des - Asp , lie ) -
All in sodium-depleted dogs did not alter any aspect of renal function,
indicating a minor physiological role for AIII in the control of renal
function.
It has been reported that in both man and dog, a small proportion
of the total circulating immunoreactive angiotensin is in the
heptapeptide form, whereas the plasma of the rat contains approximately
equal amounts of All and AIII (Caravaggi et al. , 1976; Semple et al.,
1976; Semple and Morton, 1976), suggesting that in the rat, AIII may
have a physiological role. Recently, Harris and Munro, (1984) compared
the abilities of All and AIII to reverse the natriuretic and diuretic
effects of converting enzyme inhibition (teprotide) in anaesthetised
rats. They found that systemic infusion of teprotide resulted in a
slight decrease in arterial pressure and marked increases in urine flow
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and sodium excretion. Both All and AIII reversed the renal responses to
teprotide, although All was found to be more potent than AIII. These
results suggest that in the rat, AIII may contibute to the regulation of
renal sodium and water excretion.
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EVIDENCE FOR A DIRECT TUBULAR ACTION OF ANGIOTENSIN II
Evidence for a direct effect of All on tubular transport has been
obtained from studies on the kidney in vivo and on isolated renal and
non-renal tissues.
Vander (1963) using stop-flow experiments in dogs, showed that
angiotensin infusion elevated the distal tubular concentrations of
sodium and suggested that angiotensin might act to inhibit the distal
tubule sodium transport mechanism. A non-specific pressor effect of the
peptide was ruled out as equipressor doses of noradrenaline did not
produce similar effects on the distal tubular sodium concentrations.
Leyssac (1964; 1965) observed that infusion of All increased proximal
tubular occlusion time and suggested that All inhibits proximal tubular
sodium reabsorption. Healy and Elliott (1970) found that large doses of
All resulted in decreased medullary concentrations of sodium chloride
and urea, suggesting that angiotensin has an effect on the ascending
limb of the loop of Henle.
This suggestion of a direct action of the peptide at a site in the
medulla was supported by a recent study in which angiotensin was shown
to exert a primary antidiuretic action independent of changes in GFR or
circulating vasopressin (Levens et al., 1981d). Further evidence for a
direct effect of angiotensin on tubular transport was provided by Healy
and Elliott (1971) who demonstrated that angiotensin-induced natriuresis
in conscious rabbits occurred even when the increase in blood pressure
was prevented by haemorrhage. In addition, Barraclough et al. , (1967)
showed that infusion of low doses of All decreased urine flow and sodium
excretion without significantly altering GFR. Similarly, Johnson and
Malvin (1977) reported that low doses of All markedly reduced urine flow
and sodium excretion in the absence of changes in GFR. Although there
were associated changes in renal plasma flow and filtration fraction,
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these changes did not correlate with the observed excretory responses.
While suggesting a direct effect of angiotensin on tubular reabsorption,
these clearance studies involving infusion of angiotensin or converting
enzyme inhibitors did not allow separation of the haemodynamic effects
of the peptide from possible direct effects on transport.
MICROPUNCTURE STUDIES
Using in vivo stationary microperfusion techniques, Lowitz et al.,
(1969) found that peritubular capillary perfusion with high doses of All
(2 x 10 ^ M) resulted in inhibition of distal tubular fluid reabsorption
although no effect on proximal tubular reabsorption was observed. In
contrast, using free-flow micropuncture techniques, Steven (1974)
reported that proximal tubular fluid reabsorption was inhibited when the
—8
peritubular capillaries were perfused with 2 x 10 M All.
Spinelli and Walther (1979) applied All to the decapsulated
cortical surface of the rat kidney and found stimulation of proximal
tubular fluid reabsorption at 10 ^M, but inhibition at 10 ^M. Harris
and Young (1977) investigated the effects of All on the steady-state
sodium concentration gradient (A C ) in rat proximal tubules using
IN a
stationary microperfusion combined with perfusion of the peritubular
capillaries. They found that high concentrations (10 ^M) inhibited,
while low concentration (10 ^M) stimulated proximal A
addition, they found no effect of angiotensin on trans-epithelial
potential difference as measured by the steady-state distribution of
chloride across the epithelium. These results suggest that angiotensin
has a direct biphasic effect on proximal tubular sodium reasorption,
although an effect due to changes in proximal tubular sodium
permeability cannot be ruled out. More recently, Harris et al., (1984)
found that acute converting enzyme blockade resulted in a reduced
proximal tubular fluid reabsorption in both normotensive and two-kidney,
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one-clip Goldblatt hypertensive rats.
Although it is possible that the reduced rates of tubular fluid
reabsorption were due to the direct effects of altered renal
haemodynamics and secondary alterations of the physical factors in the
peritubular capillaries, these results support the possibility of a
direct effect of All on proximal tubular reabsorption and provide
evidence that the peptide contributes to the maintenance of the rate of
proximal fluid reabsorption.
STUDIES USING ISOLATED SODIUM-TRANSPORTING EPITHELIA
To avoid the complicating haemodynamic factors encountered in the
intact kidney, the action of angiotensin on a variety of isolated
sodium-transporting epithelia has been studied. However, the results of
these studies have been confusing and appeared to depend on the type of
epithelium and conditions employed.
Burg and Orloff (1968) found that high concentrations (2.5 x 10 Si)
of All did not alter the rate of fluid absorption by isolated rabbit
proximal tubules. Similarly, angiotensin did not affect sodium
transport by toad skin (Barbour et al. , 1964), toad bladder (Coviello
and Crabbe, 1965) or isolated kidney cortex slices (Healy and Douglas,
1968). In contrast to these findings, McAfee and Locke (1967) reported
that angiotensin stimulated sodium transport by a frog-skin preparation,
whereas angiotensin was found to inhibit isotonic absorption of salt and
water by rabbit gall bladder in vitro (Leyssac et al., 1974). Further
evidence for a direct effect of angiotensin on epithelial transport was
provided by the study of Healy et al. , (1976) in which physiological
-11 -9
doses of the peptide (10 to 10 M) were found to inhibit sodium
transport in the main duct of the rabbit mandibular gland in vitro. In
addition, Crocker and Munday (1967) found that angiotensin stimulated
fluid transfer by isolated everted sacs prepared from the jejunum of
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adrenalectomised and nephrectomised rats. This finding was supported by
the finding that the small intestine in vivo and the isolated large and
small intestines respond to All with net absorption of sodium and water
-12 -11
at low doses (10 - 10 M) and an inhibition of sodium and water
-9 -8
transport at high doses (10 - 10 M) (Davies et al., 1970; Bolton et
-12
al., 1975). Munday et al., (1971) reported that low doses (10 M) of
All increased the rate of active sodium extrusion by rat kidney cortex
slices. This effect did not involve cyclic AMP, but was blocked by
inhibitors of the translation stage of protein synthesis (Munday et al.,
1972). Further evidence for a direct effect of angiotensin on renal
tubular sodium transport was provided by Simmons (1978) using monolayer
cultures of dog kidney cells (MDCK cell-line). He showed that net
sodium transport was stimulated by low concentrations of All (10 ^M).
Similar findings were reported by Simpson and Goodfriend (1984) who
-10 -9 22 +
found that low concentrations of All (10 and 10 M) stimulated Na
efflux from cultured proximal tubule cells. In addition, Schuster et
al., (1984) demonstrated that low concentrations (10 ^M) of angiotensin
stimulated, while high concentrations (10 ^M) inhibited, fluid
reabsorption by the isolated rabbit proximal tubule and concluded that
angiotensin exerts a direct biphasic effect on proximal tubular fluid
reabsorption.
These studies provide evidence that angiotensin exerts a direct
action on transepithelial sodium and fluid transport, either inhibitory
or stimulatory, depending on the hormone concentration and the
properties of the epithelium used.
RENAL TUBULAR ANGIOTENSIN II RECEPTORS
Freedlender and Goodfriend (1977) demonstrated the presence of two
125
classes of specific ( I ) All-binding sites on isolated rat renal
tubular fragments. The concentrations of the binding sites varied as a
-12
function of sodium balance and binding of All (10 M) resulted in
22 +
increased extrusion of Na from the tubules. More recently Brown and
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Douglas (1982; 1983) identified specific ( I ) All-binding sites on
isolated rat renal brush border membranes and in basolateral cell
membranes isolated from rat and baboon renal cortical tissue. The
affinity of the brush border binding sites was found to be approximately
3-fold lower than that of the basolateral membrane binding sites.
The presence of specific binding sites for angiotensin on renal
tubules supports the finding that angiotensin exerts a direct effect on
proximal tubular transport. Also, the presence of two distinct binding
sites on the same epithelial cell (Brown and Douglas, 1983) suggests
that there may be more than one mechanism whereby angiotensin influences
tubular transport.
MECHANISM OF TUBULAR ACTION
Although there is evidence for a direct effect of All on tubular
reabsorption, the mechanism underlying both the stimulatory and
inhibitory responses to the peptide remain unclear. Stimulation of net
sodium transport across frog-skin was associated with an increase in
short circuit current (McAfee and Locke, 1967), while the reductions in
net reabsorption of sodium by the isolated rabbit mandibular gland
(Healy et al. , 1976) were linked to depolarisations of the
trans-epithelial p.d., suggesting that in these tissues, angiotensin
influences epithelial transport by electrogenic mechansims.
In contrast, the action of All on epithelial transport in the small
intestine in vivo, the colon in vivo, the gallbladder in vitro, the
proximal tubule in vivo and the isolated rabbit proximal convoluted
tubule occurred in the absence of changes in electrical potential
difference, suggesting that in these tissues, angiotensin alters
epithelial transport via electoneutral mechanisms (Leyssac et al., 1974;
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Bolton et al., 1975; Harris and Young, 1977; Levens et al., 1981b;
Schuster et al., 1984).
Recently it was shown that stimulation of water absorption from the
rat jejunum by All was mediated by release of noradrenaline from
sympathetic nerve endings in close proximity to the transporting
epithelial cells (Levens et al., 1979). In addition, Levens et al.,
(1981c) found that meclofenamate and indomethacin abolished the
inhibition of jejunal water transport produced by high concentrations of
All, and suggested that the response of the rat jejunum to high doses of
All may be mediated by prostaglandins. Therefore, it is possible that
as for the rat jejunum, the effect of low doses of All on proximal
tubular reabsorption may be mediated by noradrenaline released from
adrenergic nerve endings. Indeed, Bello-Reuss (1980) demonstrated that
fluid absorption by the isolated rabbit proximal convoluted tubule was
stimulated by high concentrations of noradrenaline (10 ^M). This
finding provides direct evidence for an effect of catecholamines on the
rate of fluid transport by the proximal convoluted tubule. Thus, it is
possible that noradrenaline release might be a mediating step in the
action of All. Indeed, Radhi et al., (1982) found that in the rat the
a^-receptor antagonist prazosin, blocked the antidiuretic and
antinatriuretic effects of low doses (20 and 50 ng.kg. ^min ^) of All,
but not the diuretic or natriuretic effects of high doses (700
ng.kg. ^min *) indicating that there is some involvement of the
sympathetic nervous system in the renal response to low doses of All,
but not in the response to high doses of the peptide.
However, angiotensin has been shown to have a stimulatory effect on
sodium efflux from cultured kidney tubules (Simpson and Goodfriend,
1984) , a stimulatory effect on net sodium transport in cultured MDCK
cell monolayers (Simmons, 1978) and a biphasic effect on isolated
proximal tubular reabsorption (Schuster et al., 1984). As it is likely
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that these preparations were devoid of adrenergic nerve connections, it
would appear that All can exert a biphasic effect on proximal tubular
reabsorption independent of the sympathetic nervous system. Such a
direct effect is probably mediated by binding of the peptide to the
specific binding sites on the basolateral membrane. The intracellular
mechanism whereby All affects tubular reabsorption remains unknown,
although it is possible that the peptide may act via changes in
intracellular cyclic AMP levels and/or cytosolic calcium concentration
(Peach, 1981;Harris and Navar, 1985).
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DRIVING FORCES FOR FLUID ABSORPTION
BY THE PROXIMAL TUBULE
The reabsorption of fluid and solute by the proximal tubule
involves the complex interaction of active and passive processes across
the tubular epithelium and uptake of the reabsorbate by the peritubular
capillaries. Sodium diffuses down its electrochemical concentration
gradient from tubule lumen into the ceil, and is then actively
transported into the interstitial space, with water following passively.
Uptake of this reabsorbate from the interstitial space into the
peritubular capillary is determined by the balance of Starling forces
across the capillary wall.
HISTORICAL PERSPECTIVE
It has been generally accepted that volume absorption in leaky
epithelia ie, proximal tubule or small intestine, is an isotonic
process. Walker et al. , (1941) compared the relative osmolalities of
proximal tubular fluid and plasma and found the tubular fluid to be
slightly hypotonic to plasma. However, as the relative osmolality
differences were small they concluded that the tubule contents during
and after reabsorption of large amounts of fluid remained in osmotic
equilibrium with plasma. In addition, Gottschalk and Mylle (1959)
reported that proximal tubular fluid samples were isotonic to venous
plasma under a variety of conditions. Furthermore, it was demonstrated
that the osmolality of the luminal fluid did not change during volume
absorption in either the proximal convoluted tubule (Kokko et al., 1971)
or the proximal straight tubule (Schafer et al., 1974).
Curran and Macintosh (1962) demonstrated that osmotic volume flow
could occur between two isosmotic solutions if they were separated by a
central compartment bounded by membranes of differing permeability and
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suggested that the presence of a hypertonic central compartment within
epithelia might be responsible for apparent isotonic absorption.
Diamond and Bossert (1967) then modified the Curran and Macintosh
hypothesis by proposing that active solute transport from luminal
solutions into unstirred intercellular spaces might raise the osmolality
of the latter thereby providing a driving force for transcellular water
flow.
Recently however, evidence has been provided which suggests that
the standing gradient hypothesis of Diamond and Bossert may either not
apply and/or be inadequate to account for isotonic fluid absorption in
the proximal tubule. The diffusional resistance of the paracellular
pathway in the proximal tubule is very low and it has been suggested
that this lateral intercellular space provides insufficient resistance
to solute diffusion to permit the generation of significant osmotic
gradients and that the interspace may be in diffusional equilibrium with
peritubular solutions (Lutz et al. , 1973; Schafer et al. , 1975; 1977;
Andreoli and Schafer, 1979a; 1979b). The hydraulic conductance of the
proximal tubular epithelium was estimated by Schafer and Andreoli to be
in the range of 3,000 - 4,000 ym.sec a value much greater than
anticipated by the standing gradient theory, suggesting that very small
osmotic gradients between luminal and peritubular solutions can drive
proximal tubular absorption (Andreoli et al.,1978; Schafer et al.,
1978b; Andreoli and Schafer, 1979a; 1979b). Finally, the prediction of
intercellular space hypertonicity in the standing gradient hypothesis
depends in part on the assumption that active solute transport is
confined to the apical regions (Diamond and Bossert, 1967). However,
Kyte (1976) showed that (Na ,K )-ATPase activity was uniformly distri¬
buted along the paracellular pathway. If this activity is associated
with the sites for active Na transport into the intercellular spaces,
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then it is likely that the net diffusion resistance for solute movement
from intercellular spaces to interstitium is less than that proposed by
the standing gradient theory.
EXTERNAL SOLUTION DRIVING FORCES
As a result of these findings it was proposed that external
solution driving forces for net volume absorption might account for
fluid absorption by the proximal tubule (Andreoli and Schafer, 1978;
1979a; 1979b). Indeed, given the high transepithelial conductance of
the proximal tubule it was calculated that relatively small osmotic
gradients between luminal and peritubular fluids could provide the
driving force for the rates of fluid absorption observed in vivo and in
vitro, and it was suggested that a small degree of effective luminal
hypotonicity might drive proximal tubular fluid transport (Andreoli and
Schafer, 1978; 1979a; 1979b).
Two separate, but not mutually exclusive mechanisms were proposed
to account for the development of such effective transepithelial
osmolality gradients. First, the generation of axial anion asymmetry
between luminal and peritubular solutions. Second, the development of
trivial degrees of luminal hypotonicity as a consequence of salt
absorption.
AXIAL ANION ASYMMETRY
Proximal tubular sodium reabsorption is accompanied by tubular
fluid acidification which results in the preferential absorption of HCO^
and an increase in the tubular fluid to peritubular solution CI
concentration ratio (Schafer et al., 1974; Neumann and Rector, 1976;
Schafer and Andreoli, 1976; Warnock and Burg, 1977). The development of
a rising luminal CI concentration and a falling HCO^ concentration
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along the proximal tubule produces an osmotic driving force for fluid
absorption if the reflection coefficient for HCO^ exceeds that for CI ,
even when luminal and peritubular fluid osmolalities are identical
(Schafer et al., 1975; 1977; Andreoli and Schafer, 1979a; 1979b).
The possibility that axial anion asymmetry provides the driving
force for isotonic fluid absorption was examined by Schafer et al.,
(1975; 1977). Using isolated rabbit proximal straight tubules, perfused
with a CI Krebs-Ringer (KR) solution (HCO^ = 3.6 mM, CI = 138 mM) and
bathed with a HCO^-KR solution (HC02=25mM; CI =113 mM), they found
that fluid absorption was inhibited by approximately 60% by either
cooling to 21°C or by addition of 0.1 mM ouabain to the bathing medium.
In the absence of anion concentration gradients, ie, when both perfusate
and bathing solutions were identical, either ouabain or cooling reduced
fluid absorption to zero. These results suggest that fluid absorption
from tubules perfused with CI -KR solution and bathed with HCO^-KR
solution is dependent upon active sodium chloride absorption, which
accounts for about two-thirds of the fluid absorption and passive sodium
chloride absorption driven by a favourable electrochemical gradient for
NaCl, accounting for about one-third of fluid absorption in the pars
recta.
Chloride is absorbed passively down its concentration gradient.
Since the permeability to chloride exceeds that to bicarbonate at least
in proximal tubules of superficial nephrons (Fromter et al., 1973; Berry
et al. , 1978; Holmberg et al. , 1981), a chloride bicarbonate bi-ionic
potential develops, oriented lumen positive (Fromter et al., 1973;
Kokko, 1973; Barratt et al., 1974; Schafer et al., 1974; Berry et al.,
1978). This positive voltage drives passive Na+ absorption. The
passive component of NaCl absorption presumably occurs through the low
resistance paracellular pathway. There may also be passive NaCl
absorption due to solvent drag, although the extent of this remains
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controversial (Fromter et al., 1973; Andreoli et al., 1979; Jacobsen et
al., 1982).
Thus, an effective osmotic driving force for fluid absorption is
generated as a consequence of the axial anion asymmetry resulting from
preferential HCO^ absorption if the reflection coefficient for HCO^
exceeds that for CI (Schafer et al., 1975; 1977; Andreoli and Schafer,
1979a; iy/9b). in this respect, most early studies showed that the
reflection coefficient of NaHCO^ exceeded that for NaCl (Kokko et al. ,
1971; Fromter et al., 1973; Schafer et al., 1975). In contrast,
Hierholzer et al. , (1980) reported that the reflection coefficients for
NaHCO^ and NaCl were approximately equal. However, a more recent study
showed that the reflection coefficient for NaHCO^ was slightly greater
than that for NaCl (Green and Giebisch, 1984).
This mechanism of axial anion asymmetry is not restricted to Na
HCO^ and NaCl but applies to any solute preferentially absorbed in the
early regions of the proximal tubule, provided that the reflection
coefficient of that solute is relatively high compared with the solutes
remaining in the tubular fluid. Indeed, it has been suggested that
preferential absorption of acetate, glucose and amino acids, which have
reflection coefficients greater than that for sodium chloride or sodium
bicarbonate produces an effective osmotic driving force for fluid
absorption (Neumann and Rector, 1976; Schafer and Andreoli, 1976;
Andreoli and Schafer, 1979a; 1979b; Hierholzer et al. , 1980; Green and
Giebisch, 1984).
LUMINAL HYPOTONICITY
To determine whether slight luminal hypotonicity could provide an
osmotic driving force for proximal tubular fluid absorption, Schafer et
al., (1978a) measured the spontaneous rates of fluid absorption
occurring in isolated proximal straight tubules perfused with
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symmetrical sodium chloride solutions lacking HCO^. They found that net
fluid absorption was about 0.2 nl.mm ^.min ^ and that net fluid
absorption was inhibited by cooling or ouabain but was unaffected by the
carbonic anhydrase inhibitor ethoxzolamide. From these results it was
concluded that fluid absorption depended on "simple" active sodium
absorption and that the associated change in transepithelial potential
difference to lumen negative values, was the major driving force for
passive CI absorption (Andreoli and Schafer, 1978; Schafer et al., 1978
a). However, in contrast to this rheogenic sodium transport providing
the driving force for passive paracellular CI absorption in the
straight segment of the proximal tubule, the active component of
chloride absorption across the superficial and mid-cortical proximal
convoluted tubules is neutral and transcellular (Berry and Rector,
1980). This process generates no transepithelial P.D. and can be
blocked by anion transport inhibitors (eg, SITS, furosemide). Indeed,
there is little evidence of simple rheogenic sodium transport capable of
driving passive chloride absorption through paracellular shunt pathways
in the convoluted segment of the proximal tubule.
Andreoli and Schafer (1978) calculated that due to the high
hydraulic conductance of the epithelium, a fall in the luminal NaCl
concentration of only 0.42-0.60 mM (undetectable by current methodology)
would be required to account for the rate of fluid absorption (0.20 nl.
mm ^.min ^) observed in isolated proximal straight tubules perfused and
bathed with symmetrical NaCl solutions. Such a decrease in luminal NaCl
concentration represented a fall in luminal osmolality of 0.65 mosmol/
kg.H^O, (ie, a 0.22% decrease in luminal osmolality). Therefore, they
concluded that a slight luminal hypotonicity would develop as a result
of active sodium and passive chloride absorption, thereby providing a
driving force for fluid transport across the epithelial wall and that a
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steady state equilibrium is achieved between luminal and bathing
solutions when fluid absorption occurs.
There is evidence for the existence of such a mechanism in the in
vivo proximal tubule. Bishop et al., (1978) found that the osmolality
of proximal luminal fluid was significantly lower than that of systemic
plasma. More recently, Green and Giebisch (1984) found that the in vivo
proximal tubule could generate a small cryoscopic luminal hypotonicity
when both the tubule and peritubular capillaries were perfused with
sodium chloride solutions, although when HCO^ was added to the peri¬
tubular capillary perfusate, no luminal hypotonicity was generated, even
though fluid reabsorption was increased. In addition, using free-flow
micropuncture techniques in rats, Liu et al., (1984) observed that
luminal hypotonicity developed along the length of the proximal convol¬
uted tubule. Together, these results indicate that in the rat proximal
convoluted tubule, luminal hypotonicity and reabsorbate hypertonicity
does occur.
DOMINANCE OF AXIAL ANION ASYMMETRY
The relative contributions of axial anion asymmetry and luminal
hypotonicity to proximal tubular fluid absorption were determined using
isolated proximal straight tubules perfused and bathed with symmetrical
HCO^ - KR solutions (114 mM CI and 25 mM HCO^) (Schafer and Andreoli,
1976). Under these conditions, (ie, when tubules were exposed to
solutions resembling glomerular ultrafiltrate and peritubular fluid) the
net rate of fluid absorption was 0.46 nl.mm ^.min ^, and the mean
intratubular CI concentration increased to 122.ImM. From these
findings and previously determined values for the hydraulic conductance
and ionic reflection coefficients, Andreoli and Schafer (1979a; 1979b)
calculated that approximately 90% of the effective osmotic driving force
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for fluid transport in the proximal straight-tubule was referable to the
tubular fluid CI /HCO^ concentration ratio, and that the remainder of
the driving force for fluid transport was due to a 0.2 mM reduction in
the tubular fluid concentration. Thus the development of axial anion
asymmetry is the dominant driving force for proximal tubular fluid
absorption. Similarly, Green and Giebisch (1984) suggested that
although the in vivo proximal tubule has the ability to generate a
luminal hypotonicity, normally the effective osmotic gradients depend
largely on preferential reabsorption of solutes in the early part of the
tubule (ie, development of axial solute asymmetry).
Thus it would appear that the development of axial solute asymmetry
due to preferential organic anion absorption, preferential
non-electrolyte absorption and tubular acidification is the major
driving force for fluid absorption in the in vivo mammalian proximal
tubule (Andreoli and Schafer, 1979a; 1979b; Green and Giebisch, 1984).
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ROLE OF PERITUBULAR STARLING FORCES IN THE
REGULATION OF PROXIMAL TUBULAR FLUID REABSORPTION
In the proximal tubule in vivo, solute and fluid are transported
from tubular lumen to the interstitial space by the mechanisms described
in the previous section. This represents the first step in the reabsorp-
tion process. The second step involves uptake of the reabsorbate from
the interstitial space into the peritubular capillaries. Uptake of
reabsorbate into the peritubular capillaries is determined by the
balance of Starling forces across the capillary wall.
Evidence has been provided both in support of and against the
hypothesis that peritubular physical forces play an important role in
the control of proximal tubular fluid reabsorption. Using micropuncture
techniques, Lewy and Windhager (1968) found that increasing peritubular
capillary hydrostatic pressure by partial constriction of the renal vein
resulted in a decrease in the proximal tubular transport rate. This
finding has been confirmed in both hydropenic and volume expanded rats
(Sato, 1975; Burnett et al., 1982). Using free-flow micropuncture and
microperfusion techniques, it was demonstrated that the absolute rate of
proximal reabsorption varied directly with the oncotic pressure in the
efferent arterioles (Brenner et al. , 1969; Brenner and Troy, 1971). In
addition, a direct relationship between efferent arteriolar protein
concentration and proximal saline reabsorption was reported by Weinman
et al. , (1971). These results, together with findings of Spitzer and
Windhager (1970) that the rate of proximal fluid reabsorption correlates
with the colloid concentration in the peritubular capillaries support
the hypothesis that peritubular capillary physical forces play an
important role in the control of proximal tubular reabsorption, ie, that
an increase in oncotic pressure or a decrease in hydrostatic pressure in
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the peritubular capillaries will act to increase the rate of proximal
reabsorption.
However, several studies have failed to find a relationship between
proximal reabsorption and peritubular physical forces. Indeed several
groups reported that perfusion of the peritubular capillaries with
colloid-free solutions did not affect the rate of proximal reabsorption
as compared with normal blood perfusion or with the addition of albumin
to the perfusate (Rumrich and Ullrich, 1968; Baldamus et al., 1969;
Lowitz et al., 1969). Similarly, Bank et al., (1972) found that
microperfusion rate, but not the peritubular capillary oncotic pressure
affected proximal tubular reabsorption. In addition, Conger et al. ,
(1976) found that perfusion of the peritubular capillaries with colloid
free solutions or hyperoncotic plasma did not alter the absolute rate of
proximal reabsorption as compared with normal blood perfusion.
Furthermore, it was found that proximal tubular reabsorption was
unchanged during systemic infusion of the vasodilators acetylcholine,
bradykinin and prostaglandin in rats, despite marked decreases in
oncotic pressure and increases in hydrostatic pressure in the
peritubular capillaries (Bayliss et al., 1976).
Ott et al., (1975) investigated the effect of increased peritubular
oncotic pressure on proximal tubular reabsorption in both hydropenic and
volume expanded dogs. They found that increases in peritubular
capillary oncotic pressure increased proximal reabsorption in the volume
expanded dogs, but not in the hydropenic animals and suggested that
volume expansion alters the effect of increased peritubular oncotic
pressure on proximal tubular reabsorption. These results are consistent
with the view that extracellular volume expansion increases passive
backflux. According to this view, a reduction in colloid osmotic
pressure or an increase in hydraulic pressure in the peritubular capil¬
laries would reduce uptake of fluid from the interstitial and intercel-
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lular spaces and increase interstitial pressure. The lateral interspace
would dilate and mechanically increase the permeability of the tight
junctional complex. An increased fraction of the transported solute
would leak back into the lumen and net solute and water reabsorption
would be reduced.
Several studies have shown that during conditions of reduced
proximal reabsorption (ie, during volume expansion or increased renal
venous pressure) the permeability of the tight junctional complexes as
measured by electrical conductivity or permeability to large solutes
(ie, raffinose or sucrose) is increased (Boulpaep, 1972; Seely, 1973;
Grandchamp and Boulpaep, 1974). Therefore it is possible that increases
in the permeability of the tight junctional complexes and increased
backflux are a prerequisite for increased peritubular oncotic pressure
to result in increases in proximal reabsorption.
However, an increase in tight junction permeability would cause
increased backleak only of those solutes whose concentrations in the
luminal fluid fall below their respective plasma concentrations. Thus
an increased tight junction permeability would be expected to inhibit
reabsorption of glucose, amino acids and NaHCO^ but actually enhance
NaCl reabsorption because the electrochemical gradient for Na+ and CI
along the proximal convoluted tubule favours absorption. However, it
was found that extracellular volume expansion inhibited NaCl and volume
absorption in the proximal tubule perfused in vivo with a high chloride
and low bicarbonate solution (Alpern and Rector, 1983). As the
orientation of the NaCl concentration gradient favoured passive
absorption, the effect of volume expansion on NaCl and fluid absorption
could not have been due to increased tight junction permeability, and
therefore must have been due to inhibition of active transcellular NaCl
transport. The mechanism whereby volume expansion could inhibit
transcellular NaCl transport remains unclear.
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Studies using isolated perfused proximal tubules have demonstrated
that removal of protein from the bathing solution results in inhibition
of fluid absorption without any associated changes in transepithelial
P.D. or paracellular permeability (Imai and Kokko, 1972; 1974; Berry and
Cogan, 1981; LaPointe et al., 1983). In addition, removal of protein
from the bathing solution was found to inhibit only NaCl absorption by
the isolated proximal tubule, and not glucose or NaHCO^ absorption
(Berry and Cogan, 1981). Furthermore, Berry (1983) demonstrated that
removal of protein from the bathing solution resulted in a 60% reduction
in volume absorption by the isolated proximal tubule. Cooling the
tubule to 20°C was found to have no further effect on net fluid
absorption, while reversing the procedure, cooling first followed by
removal of bath protein, was found to give similar results. These
results suggest that removal of protein from the bathing solution
inhibits NaCl and fluid absorption by the isolated proximal tubule by
inhibiting active neutral transcellular NaCl transport.
Although the role of physical factors in the regulation of proximal
tubular reabsorption is controversial, it appears that peritubular
Starling forces do affect proximal reabsorption under certain conditions,
ie, during changes in extracellular volume. Indeed, it has been sug¬
gested that altered intrarenal physical forces play an important role in
mediating the decrease in proximal reabsorption during extracellular
volume expansion, and that the increase in urinary sodium and water
excretion observed during volume expansion is due largely to the
decreased rate of reabsorption by this segment of the nephron (Landwehr
et al., 1967; Bank, 1970; Knox and Haas, 1982). The effects of
peritubular Starling forces on proximal reabsorption appear to be
mediated by an increase in the permeability of the tight junctional
complex and thus an increase in passive backflux of those solutes whose
tubular fluid concentration falls below their plasma level (ie, glucose,
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amino acids and HCO^), and by inhibition of active neutral transcellular
NaCl transport.
In addition to intrarenal physical forces (peritubular Starling
forces), several factors appear to play a role in the physiological
control of proximal tubular fluid reabsorption. These include; the
filtered load of specific solutes, the renal nerves and various hormonal
factors (angiotensin 11, catecholamines, natriuretic hormone, and
prostaglandins). The interaction between these factors and their




As discussed in the literature review, All administration has been
shown to elicit dose-dependent effects on renal excretory function.
Most studies have indicated that the antinatriuretic and antidiuretic
effects of All occur when low doses (1-50 ng.kg.min *) are administered,
while infusion of larger doses may lead to a diuresis and natriuresis.
Since there are usually associated reductions in renal blood flow and
glomerular filtration rate, the antinatriuretic effects of All could be
the consequence of primary haemodynamic effects (Navar and Langford,
1974). However, several studies have suggested that this explanation
may not fully account for the effects of All on sodium excretion.
Barraclough et al., (1967) reported that infusion of low doses of All in
conscious rats resulted in significant reductions in urine flow and
urinary sodium excretion in the absence of changes in glomerular
filtration rate. In addition, Johnson and Malvin, (1977) showed that
reductions in urine flow and sodium excretion during intra-arterial
infusions of low doses of All did not correlate with changes in GFR,
renal plasma flow or filtration fraction. These findings suggest that
the antinatriuretic effects of All may be due to a direct stimulatory
action of the peptide on tubular sodium reabsorption.
An action of All on tubular reabsorption has also been postulated
to account for the natriuresis observed during infusion of pressor doses
of the peptide. Indeed, Healy and Elliott, (1971) observed that in
conscious rabbits, angiotensin induced natriuresis still occurred even
when the increase in blood pressure was prevented by haemorrhage. They
suggested that angiotensin-induced natriuresis is due to a direct
inhibitory action of the peptide on tubular reabsorption.
Harris and Young, (1977) provided micropuncture evidence indicating
that All exerts a direct effect on proximal tubular sodium reabsorption.
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Using stationary microperfusion techniques they demonstrated that low
concentrations (10 ^M) stimulated, while higher concentrations (10 ^M)
inhibited, proximal tubular sodium reabsorption. Similar findings were
reported in a study using isolated perfused proximal convoluted tubules
(Schuster et al., 1984). These studies provided evidence that
angiotensin exerts a direct action on proximal tubular sodium and fluid
reabsorption.
However, it is not known whether systemic infusion of All results
in alterations in proximal tubular reabsorption or whether such changes
are involved in mediating All induced alterations in renal excretory
function. Thus, the purpose of the present study was to evaluate the
effects of systemic infusion of All on proximal tubular fluid
reabsorption and whole kidney function in anaesthetised rats, and to







All experiments were performed on adult male Wistar rats maintained
on a standard rat diet.
SURGICAL PROCEDURE
Rats were anaesthetised with a single I.P. injection of Inactin
(International Apotheke, Hamburg, West Germany) (120 mg.kg and placed
on a heated micropuncture table, thermostatically controlled to maintain
their rectal temperature at 37°C. A tracheostomy was performed and the
left carotid artery cannulated to allow blood sampling and continuous
monitoring of arterial blood pressure. Mean arterial blood pressure
(MABP) was monitored with a Bell and Howell pressure transducer (Type
4-422) and recorded on a servoscribe pen recorder. Two cannulae were
inserted into the left jugular vein for infusion of 0.9% saline, inulin
and drugs. The venous cannulae were attached to syringes containing
0.9% saline and operated by a continuous infusion pump (Braun).
The left kidney was prepared for micropuncture using a method
similar to that described by Andreucci (1978a). Briefly, the rat was
placed on its right side and a subcostal (transverse) incision made in
the left flank of the rat's abdomen. The flank incision was made using
a cautery unit. The abdominal wall was retracted using four brass pins
and the abdominal contents covered with paraffin oil to minimise
evaporative losses during surgery. The left kidney was freed from the
surrounding tissue and immobilised in a plastic cup containing
cotton wool padding. Care was taken not to damage the renal artery or
vein. The kidney was then bathed continuously with paraffin oil
preheated to 37°C to prevent it from cooling and drying out. The left
ureter was cannulated with pp 10 tubing (Portex), and urine collected
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under paraffin oil in pre-weighed tubes (2-2 ml Eppendorf).
The positions of the various cannulae are shown in Fig. 2.
EXPERIMENTAL PROTOCOLS
The experiments performed are reported in Sections 3-6.
The experiments reported in Section 3 were designed to evaluate the
renal effects of infusion of a pressor dose of All and to determine the
mechanism of angiotensin induced natriuresis. Two groups of rats were
used. In both groups, All was infused at a rate of 100 ng«min ^ for one
hour. In one group, the renal perfusion pressure of the left kidney was
permitted to increase as the systemic arterial pressure increased during
All infusion, whereas in the other group, renal perfusion pressure of
the left kidney was maintained at the control level by tightening a
snare placed around the aorta proximal to the origin of the left renal
artery. Thus, the effects of a pressor dose of All on renal function
were assessed both in the presence and absence of the accompanying
increase in renal perfusion pressure.
The purpose of the experiments reported in Section 4 was to assess
the effects of systemic infusion of low (sub-pressor) doses of All on
proximal tubular fluid reabsorption and whole kidney function. Three
groups of experiments were performed. In one group, All was infused at
a rate of 0.1 ng.min ^ for one hour. In a second group, All was infused
at successive rates of 1, 5 and 10 ng.min ^ each for one hour. A third
group of rats were infused with only 0.9% NaCl for a period of five
hours and served as time controls.
Only subtle antidiuretic and antinatriuretic effects of All were
observed in the experiments reported in Section 4. These findings were
interpreted as being consistent with the possibility that it may be
necessary to suppress endogenous angiotensin production in order to
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Thus, the experiments reported in Section 5 were designed to evaluate
the effects of systemic infusion of low doses of All on renal function,
in particular proximal tubular fluid reabsorption, in chronically sodium
loaded rats. The rats were chronically sodium loaded in an attempt to
suppress endogenous angiotensin production and thereby permit the
infused hormone to elicit a pronounced antidiuresis and antinatriuresis.
Two groups of rats were used. In one group, All was infused at a rate
of 0.1 ng.min ^ for one hour, while in the other group All was infused
at successive rates of 1 and 5 ng.min * each for one hour.
Infusion of All at rates of 0.1, 1 and 5 ng.min ^ were found not to
significantly affect renal excretory function in the experiments
reported in Section 5. These findings were interpreted as indicating
that in the chronically sodium loaded rat, endogenous angiotensin
production is not suppressed and that All is still produced in amounts
that are optimal for maximal sodium retention. Thus, in the experiments
reported in Section 6, alternative methods of suppressing endogenous
angiotensin production were employed in an attempt to facilitate the
demonstration of a pronounced antinatriuretic effect of infused All.
Two groups of rats were used. In one group, rats were chronically
sodium loaded and acutely volume expanded in an attempt to physiologi¬
cally suppress the activity of the renin-angiotensin system. All was
infused at successive rates of 5 and 10 ng.min * each for one hour. In
the second group, the rats were again chronically sodium loaded and
acutely volume expanded; in addition, these rats were treated with the
angiotensin converting enzyme inhibitor (CEI), captopril, to pharmacolo¬
gically suppress the activity of the renin-angiotensin system. All was
infused at a rate of 10 ng.min ^ for one hour during continuing conver¬
ting enzyme inhibition.
The rationale and experimental procedures for each group of rats
are described in more detail in Sections 3-6.
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MICROPIPETTES
Double barrelled glass micropipettes were made from lengths of
borosilicate capillary tubing containing a glass fibre filament (Theta
glass, Cat. No. TGC 150-15, Clark Electromedical Instruments, England).
Before pulling the micropipettes, the capillary tubing was cleaned by
soaking overnight in chromic acid. The tubing was then rinsed
repeatedly with tap and distilled water and put in an oven to dry.
Micropipettes with tip diameters ranging between 1 and 15 ym were pulled
using a Livingston pipette puller (LPP-2, Clark Electromedical). The
tip of each micropipette was viewed under a Stereomicroscope (Olympus
VMF-4) and cut to a diameter of 12-15 ym using fine watchmaker forceps.
The tip of each micropipette was then bevelled to an angle of 45° on the
diamond pasted wheel of a motor driven grinding machine (Wolfgang
Hampel, West Germany). After grinding, the micropipette tips were
cleaned by repeated immersions in chromic acid and distilled water. To
keep the tips dust free and to protect them from damage, the pipettes
were stored in an inverted glass beaker until used. Fig. 3 shows a dia¬
gram of the tip of a double barrelled glass micropipette manufactured as
described above.
SHRINKING SPLIT OIL DROPLET TECHNIQUE
The method described by Gertz (1963) and modified by Gyory (1971)
was used to determine the rate of tubular fluid reabsorption (Jv) in
straight segments of surface proximal tubules. Briefly, a proximal
tubule was punctured with a double-barrelled glass micropipette (see
Fig. 3), one barrel of which was filled with Sudan black stained castor
oil and the other with an aqueous test solution (intratubular perfusion
fluid). The intratubular perfusion fluid always contained Na+ (150 mmol
kg ^), CI (135 mmol.kg *) , Ca++ (1.5 mmol.kg *") , Acetate (10 mmol.
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kg S and HCO^ (8 mmol.kg *) and had a real osmolality of 283 mosm.
kg ^I^O. The ionic composition and osmolality of the intratubular
perfusion fluid were chosen so as to be similar to that of mid-proximal
luminal fluid. The intratubular perfusion fluid was made using only
Analar grade chemicals and fresh distilled water. It was stored at 4°C
and was kept for a maximum of 5 days. Prior to each experiment, the
intratubular perfusion fluid was filtered through a millipore filter (3
ym pore size).
A long column of castor oil (about 30-50 tubular diameters) was
injected into the tubule and then a small volume of intratubular fluid
was injected so as to split the oil column into two. The droplet was
then moved upstream from the pipette by injecting a little more oil. An
isolated droplet is shown diagrammatically in Fig. 4. The isolated
droplet was kept upstream from the site of puncture by maintaining a
slight pressure on the distal oil column. Droplets were photographed on
Ilford black and white photographic film using a 16 mm cine camera
(Vinten) triggered to expose one frame per second. A fibre optic light
source (Volpi) was used to illuminate the kidney surface for micro-
puncture and photography. In order to ensure that the rate of fluid
reabsorption was measured at steady state luminal pressure, the first
picture of each sequence was taken at least five seconds after the
droplet was formed.
DEVELOPMENT OF CINE FILM
The negatives on the 16 mm cine film were developed at 20°C using
commercial black and white film developer (Ilford Microphen), and fixed
using Kodafix solution (Kodak, England). All stages of the film
development were carried out in a dark room.
DIAGRAM OF AN ISOLATED DROPLET POSITIONED
IN A SURFACE SEGMENT OF A PROXIMAL TUBULE
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INULIN ASSAY METHODS
Either polyfructosan (Inutest, Laevosan Gessellschaft, Linz,
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Austria) or C inulin (Inulin ( C) Carboxylic acid, specific activity
3.2 mCi.mmol Amersham International PLC, Buckinghamshire, England)
was used as the clearance marker for the estimation of glomerular
filtration rate (GFR). Thus, depending on which clearance marker was
used, one of the following methods was employed to determine the inulin
concentration in urine and plasma.
(a) ANTHRONE METHOD
Urine and plasma polyfructosan concentrations were determined using
the modification by Brenner (see Andreucci, 1978b) of the method
initially described by Young and Raisz (1952). Briefly, aliquots (250
yl) of each sample (deproteinised plasma, urine, Inutest standard or
distilled water) were added to tubes containing 2.5 ml Anthrone reagent,
mixed and heated at 55°C in a water bath for ten minutes. The samples
were cooled rapidly, poured into cuvettes and the absorbance at 530 nm
determined (Unicam SP500 Series 2 Spectrophotometer). Protein was
precipitated from plasma samples by adding aliquots (50 yl) to tubes
containing distilled water (750 yl) and TCA reagent (200 yl). The tubes
were centrifuged for 15 minutes and the supernatant removed. Urine and
plasma inulin concentrations were determined in duplicate using a
standard curve constructed using Inutest standards (0.01 - 0.1 mg.ml ^).
A blank for the standard curve was constructed by adding 250 yl
distilled water to 2.5 ml Anthrone reagent. The standard colorimetric
curve was nearly linear and quite reproducible.
(b) LIQUID SCINTILLATION COUNTING TECHNIQUE
Urine and plasma C inulin concentrations were measured in dupli-
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cate in an automatic scintillation counter (KB-Wallac (1218) Rackbeta).
Aliquots (20 pi) of urine and plasma samples were added to polyethylene
vials containing 3 ml Rialuma scintillation fluid (Lumac, Holland). The
vials were sealed, shaken vigorously and loaded into the scintillation
counter. All samples had the same degree of quenching and an activity
at least ten times that of background. The scintillation counter had a
high degree of accuracy and reproducibility.
Glomerular filtration rate (GFR) was calculated using the standard
clearance formula, and expressed per gram kidney weight.
GFR (ml.min *.g *) = (U/P inulin ratio x urine flow rate)/kidney weight.
SODIUM AND POTASSIUM DETERMINATIONS
Sodium and potassium concentrations in plasma and urine were
determined using a Corning 455 flame photometer (Corning, England).
Sample dilutions were made where appropriate with distilled water.
ANALYSIS OF CINE PHOTOGRAPHS
The images of shrinking droplets on the black and white negatives
were projected onto a white screen using a single frame analysis
projector (Model 244 A Special II; L-W International, Calif, U.S.A.) and
the shrinking droplet sequences were analysed by hand using a dial
caliper (Mitutoyo, Japan). Analysis of split droplets by hand was
performed by the same person and standardised as much as possible in
order to minimise potential sources of analytical error.
Shrinking droplet half-times (tj ) were calculated from the
semi-logarithmic relationship between the corrected droplet length and
time (Gyory, 1971). Since comparisons of tubular reabsorptive capacity
were to be made between tubules within each rat and between different
rats, the rate of reabsorption was expressed as flux per unit surface
area [Jv(a)] (Gyory, 1971). All calculations of tj and Jv(a) were
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performed on a Cromemco Z-2D system two computer.
In the time control experiments (group 3) reported in Section 4,
estimates of Jv were obtained from four or five tubules in each of the
five rats during the first 60 minute infusion period (only one estimate
of Jv per tubule). For the five sets of Jv measurements, the mean
coefficient of variation was 22.3%. This value is slightly higher than
the 17% reported by Gyory (1971). Since comparisions of tubular reab-
sorptive capacity were to be made between tubules within each rat and
between different rats, the reproducibility of repetitive measurements
of Jv within the same tubular segment was not determined.
CALCULATIONS AND STATISTICAL ANALYSIS
The rate of urine production was determined gravimetrically.
Arterial haematocrit was measured using heparinised microhaematocrit
tubes (Hawksley, Ltd.). Mean arterial blood pressure (MABP) was calcu¬
lated as diastolic + 1/3 pulse pressure. Values for MABP were recorded
at 15 minute intervals during each experiment and were averaged for each
60 minute period for each animal. Estimates of Jv were obtained from
one to six tubules in each animal during each 60 minute infusion period
(only one estimate of Jv per tubule). Jv values and excretory variables
were averaged for each 60 minute infusion period in each animal. All
results refer to the overall mean values determined for each 60 minute
infusion period.
Results are expressed as means ± SEM. A one-way analysis of vari¬
ance was used to determine whether differences existed between control
period values of different groups. A two-way analysis of variance was
used to evaluate changes in paired studies (ie, between control and
experimental periods). Split plot two-way analysis of variance with
repeated measures was used to evaluate changes among groups. Signifi¬




All chemicals used were Analar grade. Angiotensin I (ile^-acetate:
Sigma); angiotensin II (val^-amide; Ciba-Geigy); captopril (SQ 14,225;
Squibb). All solutions were made up in 0.9% sterile saline at a stock
concentration of 10 "*M and stored in siliconised sterile ampoules at
-20°C. Final dilutions were made in plastic tubes during the experiment.
SECTION 3
PRESSURE DEPENDENCE OF ANGIOTENSIN-
INDUCED NATRIURESIS IN RATS
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INTRODUCTION
Angiotensin II has been demonstrated to exert a dose-dependent
effect on urinary sodium and water excretion in man, rabbit, dog, monkey
and rat (Navar and Langford, 1974). Infusion of low or sub-pressor
doses of All (1-50 ng.kg ^.min *) produces a decrease in urine flow and
sodium excretion rate (Barraclough, 1965; Barraclough et al., 1967;
Malvin and Vander, 1967; Johnson and Malvin, 1977). Infusion of high or
pressor doses of the peptide elicit a biphasic effect on urine flow and
sodium excretion rate, ie, there is an initial decrease followed by a
marked increase.
The initial phase of the response to pressor doses of All may be
explained, as can the response to low doses, by the concomitant
decreases in RBF and GFR. Although the mechanism responsible for the
natriuretic phase of the response is still not clear, several groups
have reported that the natriuretic response is not related to the
pressor response (Villarreal, et al., 1964; Louis and Doyle, 1965; Healy
and Elliott, 1971). These results suggest that a direct inhibitory
effect of the peptide on tubular reabsorption may be responsible for the
natriuretic response.
However, no micropuncture study has been carried out in order to
determine whether a direct inhibitory effect of All on tubular
reabsorption is responsible for the observed natriuresis. Thus, the
experiments described in this section were carried out to determine the
renal effects of a pressor dose of All and to determine the mechanism of




The experiments were performed on male Wistar rats (250-300g)
allowed free access to standard rat diet and tap water.
SURGICAL PROCEDURE
The rats were anaesthetised and surgically prepared for micro-
puncture as described in Section 2. However, only one cannula was
inserted into the left jugular vein." This cannula was attached to a
syringe containing 0.9% NaCl and operated by a constant infusion pump
(Braun) set to deliver 75 pl.min *. In addition to a left carotid
artery cannula, a cannula was inserted into the left femoral artery to
allow continuous monitoring of left femoral arterial pressure. Also, a
polyethylene snare was placed around the aorta between the origins of
the left and right renal arteries.
EXPERIMENTAL PROCEDURE
Immediately after placement of the jugular cannula, a priming
injection of 1 ml of 0.9% NaCl was given to replace fluid losses during
surgery and 0.9% NaCl was infused at 75 yl.min . Upon completion of
surgery, a period of 60 minutes was allowed for stabilisation of urine
production and electrolyte excretion.
The equilibration period was followed by a control period of 30-60
minutes during which 0.9% NaCl only was infused. Angiotensin II was
then added to the infusate to give a delivery rate equivalent to 100
ng.min ^ (10 ^M.min and infused for 60 minutes. There then followed
a recovery period of saline infusion. Urine was collected over 10-20
minute periods throughout the experiments.
Two groups of animals were used.
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Group 1 - Control group (n=7)
The increase in MABP that occurred during the All infusion period
was allowed to increase the perfusion pressure of the left kidney.
Group 2 - Clamped group (n=7)
The left femoral artery cannula monitored arterial pressure distal
to the aortic snare and thus the arterial perfusion pressure of the left
kidney. During the All infusion period, the snare was tightened to
prevent a rise in arterial pressure from increasing the perfusion
pressure of the left kidney. The snare was released at the end of the
All infusion period.
Since the experimental procedure for both groups 1 and 2 included a
recovery period, it was not considered necessary to perform separate
time control experiments.
Throughout the experiments, randomly selected proximal tubules were
micropunctured and rates of fluid reabsorption were determined using the
shrinking droplet micropuncture technique (Gyory, 1971). The micro-
puncture techniques are described in Section 2. At the end of each
experiment, the left kidney was removed, blotted dry and weighed.
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RESULTS
In both groups 1 and 2, urine flow and urinary sodium excretion did
not vary significantly during the initial control period, suggesting
that steady state conditions had been attained.
MEAN ARTERIAL BLOOD PRESSURE (MABP)
Mean values for the left carotid (group 1) and left femoral (group
2) arterial blood pressure are shown in Fig. 5. Mean arterial blood
pressure during the control period in group 1 was not significantly
different from that in group 2. In group 1, MABP increased from 120.7±
3.4 mmHg to 149.6 ± 4.3 mmHg (P<0.05) during All infusion. It was
noticeable that the increase in blood pressure was present throughout
the duration of the All infusion. This differs from reports that blood
pressure falls towards control levels during infusion of a pressor dose
of angiotensin (Villarreal et al., 1964; Louis and Doyle, 1965). During
the recovery period, arterial blood pressure decreased to 112.0 ± 3.7
mmHg, a value significantly lower than during the control period
(P<0.05).
There was no significant change in left femoral arterial blood
pressure during the experiments in group 2. Thus, left kidney perfusion
pressure (as indicated by left femoral arterial pressure) was kept
constant throughout the All infusion period.
URINE FLOW (Fig. 6)
In the control group (group 1), urine flow was 13.02 ± 2.63 yl.min
during the control period and 8.33 ± 2.00 yl.min ^ during the first 20
minutes of All infusion. During the latter 40 minutes of infusion,
urine flow increased to 18.56 ± 3.27 yl.min a level significantly
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FIG 6 THE EFFECT OF ANGIOTENSIN II ON
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higher than that during the control period (p<0.05). During the recovery
period, urine flow was 17.84 ± 3.58 yl.min ^, a value not significantly
different from the control value.
In the clamped group (group 2), urine flow decreased significantly
from 20.93 ± 5.9 yl.min ^ during the control period to 5.90 ± 1.88
(P<0.05) during the first 20 minutes of All infusion and to 6.22 ± 2.52
yl.min ^ (P<0.05) during the last 40 minutes of All infusion. During
the recovery period, urine flow increased to 20.22 ± 5.54 yl.min a
value not significantly different from the control value (Fig. 6).
SODIUM EXCRETION RATE
Data obtained for sodium excretion rates are shown in Fig. 7. In
the control group (group 1), sodium excretion rate was 1.02 ± 0.32 ymol.
min * during the first 20 minutes of All infusion, a value not signifi¬
cantly different from the control value (1.34 ± 0.48 ymol.min ^).
During the last 40 minutes of All infusion, the sodium excretion rate
increased to 2.54 ± 0.60 ymol.min ^, a value significantly higher than
during the control period (P<0.05). Sodium excretion remained elevated
at 2.35 ± 0.65 ymol.min ^ during the 30 minute recovery period (P<0.05).
In the clamped group (group 2), sodium excretion decreased from
2.40 ± 0.94 ymol.min ^ during the control period to 0.82 ± 0.37 (P<0.05)
during the first 20 minutes of All infusion, and to 0.72 ± 0.44 ymol.
min * (P<0.05) during the last 40 minutes of All infusion. During the
recovery period, the sodium excretion rate increased to 2.92 ± 0.91
ymol.min a value similar to the control value.
POTASSIUM EXCRETION RATE
Mean potassium excretion during the control period in group 1 was
0.87 ± 0.18 ymol.min a value significantly lower (P<0.05) than the
85
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control value in group 2 (1.29 ± 0.11 ymol.min ^). The reason for this
difference is unclear.
In group 1, the potassium excretion rate decreased from 0.87 ± 0.18
pmol.min * during the control period to 0.44 ± 0.10 pmol.min * during
the first 20 minutes of All infusion (P<0.05). During the latter 40
minutes of All infusion, potassium excretion rate increased to 0.68 ±
0.11 ymol.min \ and although this remained below the control value, the
difference was not statistically significant. During the recovery
period, the potassium excretion rate was 0.93 ± 0.17 ymol.min a value
not significantly different from the control value (Fig. 8).
In the clamped group (group 2), the potassium excretion rate
decreased from 1.29 ± 0.11 ymol.min ^ during the control period to 0.33
± 0.08 (P<0.05) during the first 20 minutes of All infusion and to 0.42
± 0.10 ymol.min ^ (P<0.05) during the last 40 minutes of All infusion.
During the recovery period, potassium excretion rate increased to 1.47 ±
0.19 ymol.min ^, a value not significantly different from the control
value (Fig. 8).
PROXIMAL TUBULAR FLUID REABS0RPTI0N (Jv)
Data obtained for mean Jv during the control, first 20 minute phase
of All infusion, the last 40 minute phase of All infusion and the
recovery period are shown in Fig. 9. Mean Jv during the control period
-4 3 -2 -1
in the clamped group (group 2) was 2.19 ± 0.23 x 10 mm .mm .sec , a
value not significantly different from the corresponding value in the
control group (group 1). As shown in Fig. 9, mean Jv did not vary
significantly during the course of the experiment in group 2.
In the control group (group 1), mean Jv was 2.61 ± 0.23 during the
control period and 2.05 ± 0.20 during the first 20 minutes of All
-4 3 -2 -1
infusion, but decreased to 1.83 ± 0.22 x 10 mm .mm .sec during the
last 40 minutes of All infusion (P<0.05). During the recovery period,
88
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FIG 10 THE EFFECTS OF ANGIOTENSIN II ON MEAN
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-4 3 -2 -1
mean Jv was 2.26 ± 0.37 x 10 mm .mm .sec , a value not significantly
different from that observed during the control period, or the last 40
minutes of All infusion.
Figure 10 shows the changes in mean Jv in the two groups of rats
when overall Jv for each All infusion period was calculated. In the
-4 3 -2 -1
control group (group 1), mean Jv was 1.87 ± 0.15 x 10 mm .mm .sec
during the All infusion period, a value significantly lower than the
/ *5 O 1
control value (2.61 ± 0.28 x 10 mm .mm .sec , P<0.05) but not
significantly different from the recovery period value (2.26 ± 0.37 x
in"4 3 "210 mm .mm
sec ^). In the clamped group (group 2) mean Jv did not vary signifi¬
cantly during the course of the experiment.
INTERNAL TUBULE RADIUS
As shown in Fig. 11, mean internal tubule radius did not vary signi¬












The results demonstrated that infusion of All at a rate of 100
ng.min * resulted in a significant increase in arterial blood pressure.
This increase was maintained throughout the duration of the All infusion
(group 1, Fig. 5). During the first 20 minutes of All infusion both
urine flow and urinary sodium excretion were not different from the
initial control values, although the potassium excretion rate was found
to be significantly reduced. However, both urine flow and sodium
excretion increased significantly during the latter 40 minutes of All
infusion. During the recovery period, urine flow and sodium excretion
were not significantly different from that observed during the latter 40
minutes of All infusion. Indeed, sodium excretion during the recovery
period was significantly higher than during the initial control period
(group 2, Fig. 7). In addition, the rate of proximal tubular fluid
reabsorption during the latter 40 minutes of All infusion was lower than
during the control period but not significantly different from that
during the recovery period. Thus, it is possible that recovery of urine
flow, sodium excretion and proximal reabsorption to control levels
following infusion of a natriuretic dose of All may take longer than 30
minutes, and that in this respect, a longer recovery period may have
been more appropriate.
Although the mechanism responsible for the natriuretic response is
unclear, it has been proposed that it is due to a direct inhibitory
effect of the hormone on tubular reabsorption independent of the
associated increase in arterial blood pressure (Healy and Elliott, 1971;
Navar and Langford, 1974). However, the results obtained from the
second group of animals do not support this hypothesis. Indeed, when
the perfusion pressure to the left kidney was prevented from increasing
during the All infusion, there was a significant reduction in both urine
flow and sodium excretion rate. These changes occurred in the absence
of a significant alteration in the rate of proximal tubular fluid
reabsorption (group 2, Fig. 10).
These results suggest that in the anaesthetised rat, the
natriuretic response to All is dependent upon the increase in arterial
blood pressure and does not involve a direct inhibitory effect of high
doses of All on proximal tubular reabsorption. These findings are in
contrast to those of Healy and Elliott (1971) who demonstrated that
angiotensin induced natriuresis in rabbits occurred even when the
increase in blood pressure was prevented by haemorrhage. These differ¬
ences may be due to a species difference, an effect of the anaesthetic,
or the use of different procedures to control renal perfusion pressure
during the infusion of a pressor dose of angiotensin II.
In the present study, infusion of All resulted in a decrease in
proximal Jv only when the accompanying rise in arterial blood pressure
was allowed to increase renal perfusion pressure. This indicates that
the observed decrease in proximal Jv was due to the increase in
perfusion pressure per se and not due to a direct inhibitory effect of
the peptide on proximal tubular fluid reabsorption. It has been
suggested that an increase in renal perfusion pressure results in an
increase in peritubular capillary and interstitial hydrostatic pressure
(Ott et al. , 1971; Earley and Schrier, 1973; Knox et al. , 1983). In
addition, using the shrinking droplet micropuncture technique, Sato
(1975) demonstrated that increases in peritubular capillary hydrostatic
pressure decreased proximal tubular fluid reabsorption. Thus, it is
possible that the natriuretic response to a pressor dose of All may
be due, in part, to a reduction in proximal tubular fluid reabsorption,
caused by increased capillary and/or interstital hydrostatic pressure
secondary to the increased renal perfusion pressure.
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The finding that internal tubule radius did not vary significantly
in group 1 suggests that the reduction in proximal Jv was not due to an
alteration in tubular geometry secondary to the increased perfusion
pressure. Similarly, internal tubule radius did not vary significantly
in group 2, indicating that there was no direct effect of All on tubular
geometry.
Several studies have provided evidence that the loop of Henle is a
major site at which alterations in intrarenal physical factors affect
urinary sodium and water excretion. Indeed, it was shown that in dogs,
an increase in renal arterial pressure resulted in increases in both
sodium excretion and free water clearance (Selkurt et al., 1965). Bank
et al., (1970) reported that elevation of systemic arterial blood
pressure by infusion of adrenaline, produced a decrease in sodium
reabsorption by the loop of Henle and an increase in sodium excretion
rate. Therefore the natriuretic response to a pressor dose of All, may
also be due in part, to reduced reabsorption by the loop of Henle,
caused by increased capillary and/or interstitial hydrostatic pressure
secondary to the increased renal perfusion pressure. An increase in
capillary and/or interstitial hydrostatic pressure may decrease the
hydrostatic pressure gradient across the wall of the thin descending
limb and thus decrease passive movement of water out of this segment.
This would result in a larger volume of less concentrated fluid being
delivered to the ascending limb and the distal tubule, and thus a
natriuresis. However, an alternative possibility is that the natriuretic
response to All may be consequent on an increased glomerular filtration
rate secondary to the increased renal perfusion pressure. As GFR was
not measured in the present study, it is not possible to determine
whether or not the changes in urinary excretion were a consequence of an
altered GFR.
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In the present study, arterial blood pressure and thus renal per¬
fusion pressure increased immediately following administration of All in
group 1. However, both urine flow and urinary sodium excretion were not
significantly altered during the first 20 minutes of All infusion. It
is possible that during this period, All may have produced a marked
intrarenal vasoconstriction thereby offsetting the diuretic and
natriuretic effect of the elevated perfusion pressure. The increase in
urine flow and urinary sodium excretion that occurred during the last 40
minutes of All infusion may have been due to a waning of the intrarenal
vasoconstriction thereby allowing the elevated perfusion pressure to
elicit a diuresis and natriuresis. The observation that when renal
perfusion pressure was prevented from increasing, infusion of All
produced a sustained antidiuresis and antinatriuresis could be inter¬
preted as support for the possibility that the waning of the intrarenal
vasoconstrictor effect of All is dependent upon an increase in renal
perfusion pressure.
It is questionable whether endogenous angiotensin production ever
reaches such natriuretic levels. Since a viable All assay was not
available, All levels in the plasma or kidney tissue were not measured
in this study. Therefore, it is not known what the endogenous All
levels were, or to what levels the circulating and/or tissue concentra¬
tions were raised during infusion of the peptide. However, Brown et
al. , (1981) measured plasma All concentrations in conscious rats
receiving systemic infusions of various doses of the peptide. They
reported that infusion of All at the rate of 270 ng.kg. ^min ^ increased
_9
circulating levels to approximately 3 ng/ml (3 x 10 M; a thirty-two
fold increase compared with controls infused with dextran). In the
present study, All was infused at a rate of 100 ng.min equivalent to
333-400 ng.kg. ^ min . Despite the fact that anaesthetised rats were
used in this study, it would be reasonable to assume that the doses of
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All employed in the present study resulted in a circulatory
-9
concentration in excess of 10 M. Although it is unlikely that such
high concentrations occur in the normal control of sodium excretion,
they might occur in pathological conditions. Indeed, very high
_9
circulating levels of the peptide (in excess of 10 M) have been
reported in the rat under conditions of sodium restriction (Oster et
al., 1973) and haemorrhagic hypotension (Semple, 1981).
SECTION 4
THE EFFECT OF INFUSION OF SUB-PRESSOR




It has been suggested that the decreased urine flow and sodium
excretion rate observed in response to low doses of All can be explained
by the concomitant changes in renal haemodynamics (Navar and Langford,
1974). However, Barraclough et al., (1967) and Johnson and Malvin,
(1977) reported that the antinatriuretic response to infusion of low
doses of All was independent of changes in GFR and suggested that low
doses of the peptide may directly stimulate tubular reabsorption.
The direct effect of All on proximal tubular reabsorption has been
investigated using in vivo micropuncture techniques and isolated
perfused tubule preparations. Using in vivo micropuncture techniques in
rats, Harris and Young, (1977) and Spinelli and Walther (1979)
demonstrated that low doses of All (10 - 10 ^M) directly stimulated
proximal tubular sodium and fluid reabsorption. In addition, Schuster
et al., (1984) found that low doses (10 ^M) of the peptide stimulated
fluid reabsorption by isolated segments of rabbit proximal convoluted
tubule.
Therefore, it is possible that the antidiuretic and antinatriuretic
response to low doses of All may be due to a direct stimulatory effect
of the peptide on proximal tubular reabsorption. To evaluate this
possibility, experiments were carried out to determine the effects of
systemic infusion of low doses of All on proximal tubular fluid reabsorp¬




All experiments were performed on male Wistar rats (250-300g)
allowed access to tap water ad libitum. The rats were anaesthetised and
surgically prepared for micropuncture as described in Section 2.
EXPERIMENTAL PROCEDURE
After placement of the jugular cannulae, a priming injection of 1
ml of 0.9% saline was given to replace fluid losses during surgery, and
0.9% saline was infused via both cannulae (total rate of 75 yl.min .
Upon completion of surgery, a priming dose of 1ml of 2% Inutest was
administered through one of the jugular cannulae and then a solution of
2% Inutest infused throughout the remainder of the experiment. Saline
was infused from the other syringe. A period of 90 minutes was then
allowed for the clearance marker to reach a steady state and for
stabilisation of renal function.
Three groups of experiments were performed.
Group 1 - Infusion of 0.1 ng.min ^ All (n = 6)
The equilibration period was followed by a 60 minute period during
which 0.9% saline and Inutest were infused. All was then added to the
syringe previously used for infusion of saline alone and infused at a
rate of 0.1 ng.min ^ for one hour. There then followed a 60 minute
recovery period during which only saline and Inutest were infused.
Group 2 - Infusion of 1, 5 and 10 ng.min ^ All (n = 7)
The 90 minute equilibration was followed by a protocol consisting
of 5 periods each of 60 minutes. During the first period (control)
saline and Inutest were both infused, as in group 1. In 3 subsequent
100
periods, All was administered from the saline syringe, at doses of 1, 5
and 10 ng.min ^. The final hour was a recovery period during which
saline and Inutest only were infused.
Group 3 - Time controls (n = 5)
The protocol used in this group differed slightly from that employed
14
in groups 1 and 2 in that C inulin (Amersham) was used instead of
Inutest as the clearance marker for GFR. After completion of surgery a
14
priming dose of 1 ml (containing 4.6 KBq - 0.124 yCi) of C inulin was
14
administered through one of the jugular cannulae. C inulin was then
infused (37.5 yl.min *) continuously throughout the remainder of the
-1 -3 -1
experiment at the rate of 344 Bq.min (9.3 x 10 yCi.min ). As in
groups 1 and 2, a 90 minute equilibration period was then allowed for
the attainment of steady state conditions. This was followed by five
14
consecutive 60 minute periods during which only saline and C inulin
were infused (each at 37.5 yl.min ^).
In all groups, the total rate of fluid administration remained
constant (75 yl.min ^). At the mid-point of each 60 minute urine
collection period, an arterial blood sample (400 yl) was taken and an
aliquot used for determination of haematocrit. The cells were separated
by centrifugation and the plasma removed. During each 60 minute urine
collection period, randomly selected surface proximal tubules were
micropunctured. Proximal tubular fluid reabsorption (Jv) was determined
using the shrinking droplet technique (Gyory, 1971). At the end of each
experiment, the kidney was removed, blotted dry and weighed.
In Fig. 12-20, statistical significance is indicated as:
*, P<0.05 when compared to control period; calculated from paired data
using two-way analysis of variance and Duncan's multiple range test.
RESULTS
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MEM ARTERIAL BLOOD PRESSURE
The results for MABP are shown in Fig. 12. In all groups, MABP re¬
mained above 100 mmHg throughout the course of the experiment. There
were no significant changes in MABP during the time control experiments
(group 3). Infusion of All at rates of 0.1,1,5 and lOng.min 1 did not
significantly increase MABP. However, time-dependent decreases in
arterial blood pressure occurred in both groups 1 and 2. The reasons
for these time-related decreases in blood pressure remain unclear.
URINE FLOW
Data obtained for urine flow are shown in Fig. 13. There were no
significant differences in the control period values for urine flow rate
between the three groups of rats (one-way analysis of variance). In the
time control experiments (group 3), urine flow rate was 18.77 ± 2.93 pi.
min 1 during the second 60 minute infusion period, a value not signifi¬
cantly different from that during the first 60 minute infusion period
(16.79 ± 3.29 pl.min . However, urine flow increased significantly to
21.15 ± 3.73, (P<0.05), 22.12 ± 4.19 (P<0.05) and 20.72 ± 4.01 pi.min"1
(P<0.05) during the last three 60 minute infusion periods respectively.
In group 1 (low dose All) urine flow did not change significantly
during infusion of 0.1 ng.min 1 All. The pattern of urine flow during
the 0.1 ng.min ^AII infusion (group 1) experiments was not significantly
different from that during the first three 60 minute infusion periods in
the time control (group 3) experiments. However, the pattern of urine
flow during the control, 1,5 and 10 ng.min 1 All infusion periods in
group 2 was significantly different (P<0.05) from that during the first
four 60 minute infusion periods in the time control experiments (group
3). Indeed, the increase in urine flow observed in the time control
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FIG 13 THE EFFECT OF ANGIOTENSIN II ON
















































experiments (group 3) did not occur in group 2 (high doses All). Thus,
infusion of All at rates of 5 and 10 ng.min * resulted in an anti-
diuresis when the effects of the peptide were compared to the effects of
infusion of saline alone.
GLOMERULAR FILTRATION RATE (GFR)
Due to technical difficulties, accurate measurements of GFR were
not obtained for the group 1 (low dose All) experiments. Glomerular
filtration rate did not change significantly during the time control
(group 3) experiments. In group 2 (high doses All) glomerular
filtration rate was not significantly altered during infusion of 1 and 5
ng.min ^ All, but decreased significantly to 0.58 ± 0.07 ml.min *.g ^
(P<0.05) during infusion of 10 ng.min ^ All. During the recovery
period, glomerular filtration rate increased to 0.94 ± 0.2 ml.min ^g \
a value not significantly different from control. These results are
shown in Fig. 14.
SODIUM EXCRETION RATE (Fig. 15)
There were no significant differences in the control period values
for sodium excretion between the three groups of rats (one-way analysis
of variance). In the time control experiments (group 3), the mean
sodium excretion rate during the second 60 minute infusion period was
2.14 ± 0.39 ymol. min ^, a value not significantly different from that
during the first 60 minute infusion period (1.73 ± 0.33 ymol.min ^).
However, sodium excretion increased to 2.79 ± 0.56 (P<0.05), 3.45 ± 0.81
(P<0.05) and 3.38 ± 0.81 ymol.min ^ (P<0.05) during the last three 60
minute infusion periods respectively.
In group 1 (low dose All) sodium excretion rate did not change
significantly during infusion of 0.1 ng. min * All. The pattern of
sodium excretion during the 0.1 ng.min ^ All infusion (group 1) experi¬
ments was not significantly different from that during the first three
105
























































60 minute infusion periods in the time control (group 3) experiments.
However, the pattern of sodium excretion during the control 1,5 and 10
ng.min * All infusion periods in group 2 was significantly different
(P<0.05) from that during the first four 60 minute infusion periods in
time control (group 3) experiments. Indeed, the increase in sodium
excretion observed in the time control experiments (group 3) did not
occur in group 2. Thus, infusion of All at rate of 5 and 10 ng. min ^
resulted in an antinatriuresis when the effects of the peptide were
compared to the effects of infusion of saline alone. However, at no
time in group 2 did infusion of All elicit a significant reduction in
sodium excretion compared with the initial control value.
PERCENTAGE OF FILTERED SODIUM WHICH WAS REABSORBED
Mean values for this parameter are shown in Fig. 16. In the time
control experiments (group 3), the percentage of filtered sodium which
was reabsorbed did not vary significantly during the first two 60 minute
periods. However, a significant reduction from 98.51 ± 0.25% during the
first 60 minute period to 97.49 ± 0.56, 96.97 ± 0.78 and 96.90 ± 0.83%
during the last three 60 minute periods respectively was observed
(P<0.05 in all cases).
As accurate measurements of GFR were not obtained for the group 1
(low dose All) experiments, it was not possible to calculate fractional
sodium reabsorption values for this group. In group 2 (high doses All),
the percentage of filtered sodium which was reabsorbed was unaffected by
the All infusion rates employed. Thus, the progressive decrease in
fractional sodium reabsorption observed in the time control experiments
(group 3) did not occur in group 2 (high doses All).
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FIG 16 THE EFFECT OF ANGIOTENSIN II ON THE MEAN






































The mean values for this parameter are shown in Fig. 17. No signi¬
ficant changes in the absolute excretion of potassium were observed in
any of the three groups.
PERCENTAGE OF FILTERED POTASSIUM WHICH WAS EXCRETED
As accurate measurements of GFR were not obtained for the group 1
(low dose All) experiments, it was not possible to calculate fractional
potassium excretion values for this group of experiments. No significant
changes in fractional potassium excretion occurred in either group 2 or
3 (Fig. 18).
HAEMATOCRIT
These results are shown graphically in Fig. 19. Haematocrit did
not vary significantly in the 0.1 ng.min ^ All experiments (group 1).
In group 2, arterial haematocrit determined during the 1 ng.min ^ All
infusion period (47.8 ± 0.7%) did not differ significantly from the
control value (48.3 ± 0.8%). However, haematocrit decreased signifi¬
cantly to 45.4 ± 0.6% (P<0.05) during the 5 ng.min ^ All period, to 43.1
± 0.7% (P<0.05) during the 10 ng.min ^ All period and to 41.6 ± 0.9%
(P<0.05) during the recovery period.
In the time control experiments (group 3), arterial haematocrit did
not vary significantly during the first two 60 minute periods. A signi¬
ficant reduction from 46.3 ± 1.4% during the first period to 43.9 ± 1.0
(P<0.05) , 42.4 ± 1.2 (P<0.05) and 41.3 ± 0.4% (P<0.05) during the last
three hours of infusion was observed. The overall patterns of arterial
haematocrit, at any given time, were not significantly different for the
three groups of rats.
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FIG 18 THE EFFECT OF ANGIOTENSIN II ON THE MEAN
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PROXIMAL TUBULAR FLUID REABSORPTION (Jv)
Data obtained for mean Jv are presented in Fig. 20. In the time
control experiments (group 3), mean Jv during the first 60 minute in-
-4 -3 -2 -1
fusion period was 2.93 ± 0.26 x 10 mm .mm .sec . Mean Jv did not
vary significantly during the first four 60 minute infusion periods,
-4 3 -2 -1
but decreased significantly to 1.92 ± 0.22 x 10 mm .mm .sec (P<0.05)
during the fifth 60 minute infusion period. Infusion of All at rates of
0.1,1,5 and 10 ng.min * did not increase proximal tubular fluid reabsorp-
tion. In group 1, (low dose All), mean Jv did not vary significantly
during the experiment. The pattern of proximal Jv during the 0.1 ng.
min * All infusion (group 1) experiments was not significantly different
from that during the first three 60 minute infusion periods in the time
control (group 3) experiments.
In group 2 (high doses All), the values obtained for mean Jv during
the 1,5 and 10 ng.min * All infusion periods were 2.24 ± 0.18, 2.20 ± 0.
-4 3 -2. -1
24 and 1.99 ± 0.10 x 10 mm .mm 'sec respectively. Although these
values were significantly lower than the initial control value (2.91 ±
-4 3 -2 -1
0.23 x 10 mm .mm .sec , P<0.05 in all cases) they were not signifi-
-4 3
cantly different from the recovery period value (1.85 ± 0.13 x 10 mm .
-2 -1
mm .sec ). Indeed, mean Jv during the recovery period was significantly
lower than during the initial control period (P<0.05) Furthermore, the
pattern of proximal Jv during the control, 1,5 and 10 ng.min * All
infusion periods in group 2 was not significantly different from that
during the first four 60 minute infusion periods in the time control
(group 3) experiments.
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FIG 20 THE EFFECT OF ANGIOTENSIN II ON MEAN











































| lng mirrVUl |5ngmiiT^All |lOng.min"Wi"
~60 l3o 3o 2A0 5)0
Time(mins)




The present study was designed to determine the effects of systemic
infusion of small (sub-pressor) doses of All on renal function, parti¬
cularly proximal tubular fluid reabsorption, in the rat.
In the time control experiments (group 3) arterial blood pressure
remained stable for the duration of the five hour experiment. However,
in groups 1 and 2, arterial blood pressure was found to decrease
progressively with time. The reasons for these observed reductions in
arterial blood pressure remain unclear. In the time control experiments
(group 3) both urine flow and sodium excretion increased during the
course of the experiment. These changes occurred in the absence of
significant alterations in arterial blood pressure or glomerular
filtration rate. The increase in urinary sodium excretion was
associated with a progressive decrease in the percentage of filtered
sodium which was reabsorbed. Although both urine flow and sodium
excretion increased during the time control experiments both absolute
and fractional potassium excretion rates did not vary during the course
of the experiment. Proximal tubular fluid reabsorption remained stable
for the first four hours of infusion but decreased significantly during
the fifth 60 minute infusion period (group 3, Fig. 20). Arterial
haematocrit was significantly reduced during the infusion of 5 and 10
ng.min ^ All. However, the finding that arterial haematocrit remained
significantly decreased during the final recovery period in group 2 and
was significantly reduced during the last three hours of infusion in the
time control experiments (group 3), suggests that the reductions observed
in this parameter were due to a time-dependent effect of systemic
infusion of isotonic saline.
Infusion of All at a rate of O.lng.min ^ (group 1) did not signifi¬
cantly alter any of the parameters of renal function measured. Indeed,
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the patterns of urine flow, urinary sodium and potassium excretion and
proximal Jv during the 0.1 ng.min ^ All infusion experiments (group 1)
were not significantly different from those during the first three 60
minute infusion periods in the time control experiments (group 3). In
group 2, the effects of infusion of All on urine flow and urinary sodium
excretion were signifciantly different compared to the effects of
infusion of saline alone (group 3). Indeed the patterns of urine flow
and urinary sodium excretion during the control, 1, 5 and 10 ng.min *
All infusion periods (group 2) were significantly different from those
during the first four 60 minute infusion periods in the time control
experiments (group 3). The significant increase in urine flow and
sodium excretion that occurred during the last three 60 minute infusion
periods in group 3 did not occur in group 2. Thus, infusion of All at
rates of 5 and 10 ng. min ^ resulted in an antidiuresis and antinatriu-
resis when the effects of the peptide were compared to the effects of
infusion of saline alone. However, these effects of All were subtle and
at no time in group 2 did All reduce urine flow or urinary sodium
excretion to levels significantly lower than the initial (ie, pre-AII)
control values.
In addition to this subtle antidiuretic and antinatriuretic effect
of All, infusion of the peptide at a rate of 10 ng.min ^ significantly
reduced GFR (Fig. 14). Proximal tubular fluid reabsorption during the
1, 5 and 10 ng.min ^ All infusion periods (group 2) was significantly
lower than the initial control value. However, proximal tubular fluid
reabsorption did not return to control levels following infusion of
these three sub-pressor doses of All, but remained significantly reduced,
suggesting that the observed reductions in proximal Jv were not due to
an inhibitory effect of All, but represented time-dependent decreases in
this parameter. Indeed, the effect of these three subpressor doses of
117
the peptide on proximal reabsorption was not significantly different to
the effect of infusion of saline alone (group 3).
Thus, the results from the present study are consistent with the
possibility that the antidiuretic and antinatriuretic effects of systemic
infusion of 10 ng.min ^ All are due, at least in part, to altered renal
haemodynamics (ie, a reduction in GFR). In addition, the present
findings do not support the concept that the antinatriuretic effect of
systemic All is due to facilitation, by the peptide, of proximal tubular
fluid reabsorption. Indeed, in the present study, infusion of All at
rates of 0.1,1,5 and 10 ng.min * did not increase proximal tubular fluid
reabsorption. However, the results from the present experiments do not
rule out the possibility that systemic All may stimulate tubular
reabsorption by more distal segments of the nephron.
It is possible that the decrease in GFR observed during infusion of
10 ng.min * All (Fig. 14) was due to the associated reduction in MABP
and not to a direct action of the peptide. However, during the recovery
period, GFR returned to control levels despite the fact that MABP
remained significantly reduced, suggesting that the observed reduction
in GFR was due to the effect of All and not the result of a reduction in
MABP.
Barraclough et al (1967) suggested that in its normal state, the
rat produces almost optimal antinatriuretic amounts of All and that
elevation of the plasma All concentration will not lead to a reduction
in sodium excretion. Also, they suggested that it may be necessary to
sodium load the animal to suppress endogenous All production in order to
demonstrate an antinatriuretic effect of infusion of low doses of the
peptide. This may explain why only very subtle antidiuretic and
antinatriuretic effects of All were observed in the present study.
It has been demonstrated that All exerts a direct stimulatory
effect on proximal tubular sodium and fluid reabsorption, with a maximum
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effect at a peritubular concentration of approximately 10 (Harris
and Young, 1977; Spinelli and Walther, 1979; Schuster et al., 1984).
This concentration is within the range found by radioimmunoassay in
normal rat plasma (Oster et al., 1973; Semple and Morton, 1976; Brown et
al., 1981). These results together with the finding by Harris et al. ,
(1984) that infusion of captopril in the anaethetised rat prepared for
micropuncture results in a 30% reduction in proximal tubular fluid
reabsorption suggest that the normal rat (ie, not sodium loaded or
depleted) produces amounts of All that are almost optimal for maximal
stimulation of proximal tubular fluid reabsorption and sodium retention.
It may therefore be necessary to suppress endogenous angiotensin produc¬
tion in order to demonstrate a stimulatory effect on proximal tubular
fluid reabsorption and a pronounced antinatriuretic effect of infusion
of exogenous hormone.
SECTION 5
THE EFFECT OF INFUSION OF SUB-PRESSOR
DOSES OF ANGIOTENSIN II ON RENAL FUNCTION
IN SODIUM LOADED RATS
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INTRODUCTION
Barraclough et al. , (1967) suggested that the rat normally produces
amounts of angiotensin that are optimal for sodium retention and that it
is probably necessary to suppress endogenous angiotensin production in
order to demonstrate an antinatriuretic effect of the infused hormone.
As discussed previously (Section 4), it is possible that this may
explain the failure to observe a stimulation of proximal reabsorption
and a pronounced antinatriuresis in response to infusion of low doses of
All in the experiments described in the previous section.
Plasma renin activity has been shown to vary inversely with dietary
sodium intake in all species examined (Brown et al., 1963;1964b; Davis
and Freeman, 1976; Sancho et al. , 1976: Wong and Zimmerman, 1982).
Alterations in dietary sodium intake have been used to alter the
activity of the renin-angiotensin system. Sodium deprivation markedly
increases plasma renin activity, kidney renin concentration and plasma
All levels while increased salt intake (sodium loading) lowers kidney
renin concentration and plasma renin activity, ie, supresses the
renin-angiotensin system (Gavras et al. , 1973; Davis and Freeman, 1976;
Mendelsohn, 1976; 1979; Fray et al., 1977; Semple, 1981). However,
intrarenal All concentrations have been found not to be suppressed to
the same extent as renal tissue renin concentrations during salt loading
(Mendelsohn, 1979; 1982). Nevertheless, the basic hypothesis is that
the activity of the renin-angiotensin system is augmented by sodium
deprivation and suppressed by sodium loading.
The combination of a high salt diet with the administration of a
mineralocorticoid such as desoxycorticosterone acetate (DOCA) has been
used to deplete kidneys of renin and suppress circulating All levels
(Potkay and Gilmore, 1973; Kaloyanides et al. , 1974; Hall et al. ,
1977a).
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Alternative methods of suppressing the activity of the renin-angio¬
tensin system have involved the use of pharmacological inhibitors or
antagonists that either block the conversion of AI to All or directly
interfere with the action of All (Hall et al., 1977b; 1979 b; Fagard et
al. , 1978; Thurston and Swales, 1978; Hollenberg, 1979; Ploth et al. ,
1979; McCaa, 1982; Navar et al., 1982; Ploth and Roy, 1982 a; Wong and
Zimmerman, 1982).
The following experiments were designed to investigate the effects
of systemic infusion of low (sub-pressor) doses of All on proximal
tubular fluid reabsorption and whole kidney function in anaesthetised
sodium loaded rats. Rats were sodium loaded in an attempt to suppress
endogenous angiotensin production and thus facilitate the demonstration
of a stimulation of proximal tubular fluid reabsorption and a pronounced




Studies were performed on sodium loaded male Wistar rats (250
-325g) maintained on a standard rat diet. Two groups of animals were
examined using the protocols described below.
Group 1 (n = 5)
Experiments were carried out on rats loaded with sodium by
replacing their drinking water with 0.9% saline for 8-10 days prior to
the experiment. In this group of animals, the effect on renal function
of infusion of All, at a rate of 0.1 ng.min , was determined. However,
as is shown in the results section, this dose of All failed to alter any
parameter of renal function measured. This may have been due to the
fact that the dose of All used was too low to elicit an antinatriuresis
and/or that the animals were insufficiently sodium loaded to suppress
endogenous angiotensin production and thereby allow the exogenous
hormone to elicit an antinatriuresis.
Thus, a second group of experiments (group 2) were performed to
evaluate the renal effects of infusion of All, at the rates of 1
and 5 ng.min in rats subjected to a more severe form of sodium
loading.
Group 2 (n = 5)
In this group, rats were sodium loaded by replacing their drinking
water with 2% saline for at least 5-6 weeks prior to the experiment.
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SURGICAL PROCEDURE
The surgical procedure employed was the same for both group of rats
and is described in Section 2.
EXPERIMENTAL PROCEDURE
After placement of the jugular cannulae, a priming injection of 1
ml of 0.9% saline was administered to replace fluid losses during
surgery, and 0.9% saline was infused from both syringes (total rate of
75 yl.min *). After completion of surgery, a priming dose ( 1 ml of 2%
solution) of Inutest was administered through one of the jugular
cannulae and followed by an infusion at 37.5 yl.min ^ throughout the
remainder of the experiment.
A period of at least 90 minutes was allowed for attainment of
steady state conditions, and was followed by a 60 minute control period,
during which the animals received only saline and Inutest. After the
control period, the protocol differed for the two groups of animals.
Group 1
All was added to the saline syringe and infused for 60 minutes at
the rate of 0.1 ng.min . There then followed a recovery period during
which only saline and Inutest were infused.
Group 2
All was added to the saline syringe and administered at the rates
of 1 and 5 ng.min ^ for each of the two subsequent 60 minute periods.
Again there was a final 60 minute recovery period during which only
saline and Inutest were infused.
As the experimental procedure for both groups included a recovery




MEAN ARTERIAL BLOOD PRESSURE (Fig. 21)
There was no significant difference in the initial arterial blood
pressure between the two groups of rats. Infusion of All at rates of
0.1,1 and 5 ng.min * did not significantly increase arterial blood
pressure. However, time-dependent decreases in this parameter occurred
in both groups. The reasons for these time-related decreases in blood
pressure remain unclear.
URINE FLOW
The results presented in Fig. 22 show that there were no significant
alterations in urine flow in either of the two groups of animals.
GLOMERULAR FILTRATION RATE (GFR)
Due to technical difficulties, accurate measurements of GFR were
not obtained for the group 1 experiments. In group 2, GFR during the 1
ng.min ^ All infusion period was 0.85 ± 0.11 ml.min ^.g ^, a value not
significantly different from the control value (0.81 ± 0.12 ml.min .
g *). However, GFR decreased to 0.54 ± 0.08 (P<0.05) during infusion of
5 ng.min * All and to 0.42 ± 0.07 ml.min ^".g * (P<0.05) during the
recovery period. These results are shown in Fig. 23.
SODIUM EXCRETION RATE
As summarised in Fig. 24 no significant change in absolute sodium
excretion occurred in either group.
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FIG 22 THE EFFECT OF ANGIOTENSIN II ON
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PERCENTAGE OF FILTERED SODIUM WHICH WAS REABSORBED
As accurate measurements of GFR were not obtained for the group 1
experiments, it was not possible to calculate values for fractional
sodium reabsorption for this group. As shown in Fig. 25 no significant
variation in this parameter occured in group 2.
POTASSIUM EXCRETION RATE (Fig. 26)
The mean potassium excretion rate during the control period in
group 1 was significantly higher than the corresponding value in group 2
(0.96 ± 0.18 vs 0.23 ± 0.10 ymol.min ^ respectively, P<0.05). The
reason for his difference is not clear. The mean rate at which potassium
was excreted was unaffected by any of the doses of All infused. However,
in group 2, mean potassium excretion during the recovery period was 0.32
± 0.11 ymol.min \ a value significantly higher than the control value
(0.23 ± 0.10 pmol.min P<0.05).
PERCENTAGE OF FILTERED POTASSIUM WHICH WAS EXCRETED (Fig. 27)
As accurate measurements of GFR were not obtained for the group 1
experiments, it was not possible to calculate values for fractional
potassium excretion for this group. In group 2, mean fractional potas¬
sium excretion was not significantly altered during infusion of 1 or
5 ng.min ^ All. However, during the recovery period, mean fractional
potassium excretion was 15.68 ± 3.14%, a value significantly higher than
the control value (7.02 ± 1.91%, P<0.05).
HAEMATOCRIT
The results presented in Fig. 28 show that there was no significant
variation in this parameter in either series of experiments.
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FIG 25 THE EFFECT OF ANGIOTENSIN II ON THE
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FIG 27 THE EFFECT OF ANGIOTENSIN II ON THE MEAN
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PROXIMAL TUBULAR FLUID REABSORPTION (Jv)
Data obtained for mean Jv are presented in Fig. 29. Infusion of
All at rates of 0.1, 1 and 5 ng.min ^ did not increase proximal tubular
fluid reabsorption. In group 1, mean Jv during the 0.1 ng.min * All
-4 3 -2 -1
infusion period was 2.67 ± 0.05 x 10 mm. mm. sec , a value signifi-
-4
cantly lower (P<0.05) than the initial control value (3.37 ± 0.15 x 10
3 -2 -1
mm. mm. .sec ), but not significantly different from the recovery
-4 3 -2 -1
period value (2.70 ± 0.25 x 10 mm. mm. sec ). In group 2, the
values obtained for mean Jv during the 1 and 5 ng.min ^ All infusion
-4 3 -2 -1
periods were 1.83 ± 0.16 and 1.87 ± 0.14 x 10 mm .mm .sec respec¬
tively. Although these values were significantly lower than the Initial
-4 3 -2 -1
control value (2.71 ± 0.20 x 10 mm .mm .sec , P<0.05 in both cases),
they were not significantly different from the recovery period value
(1.40 ± 0.13 x 10 ^mm^.mm ^.sec ^).
Thus in both groups, although the values obtained for mean Jv
during the All infusion periods were lower than the corresponding
control values, they were not significantly different from the
corresponding recovery period values. Indeed, in both groups, mean Jv
during the recovery period was significantly lower than during the
initial control period (P<0.05 in both cases).
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FIG 29 THE EFFECT OF ANGIOTENSIN II ON MEAN
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DISCUSSION
The present study was designed to examine the renal effects of
systemic infusion of low doses of All in anaesthetised sodium loaded
rats. Infusion of All at rates of 0.1, 1 and 5 ng.min ^ did not increase
arterial blood pressure or proximal tubular fluid reabsorption or
significantly affect urine flow, urinary sodium or potassium excretion,
the percentage of filtered sodium reabsorbed or the fractional excretion
of potassium. In group 2, glomerular filtration rate during the 5
ng.min ^ All infusion period was significantly lower than the control
value but not significantly different from the recovery period value.
Similarly, in both groups 1 and 2, although the values obtained for mean
Jv during the All infusion periods were significantly lower than the
corresponding control values, they were not significantly different from
the corresponding recovery period values. Indeed, both GFR and proximal
Jv remained significantly reduced following infusion of All. Thus, the
observed reductions in GFR and Jv during the All infusion periods may
not have been due to infusion of the peptide but may have represented
time-dependent decreases in these parameters. Indeed, time-dependent
decreases in arterial blood pressure occurred in both groups 1 and 2.
Therefore, the observed time-dependent decreases in GFR and proximal Jv
may have resulted from the progressive decreases in arterial blood
pressure.
The results differ from the general finding that systemic infusion
of low (sub-pressor) doses of All produce an antinatriuresis (Barraclough
et al. , 1967; Malvin and Vander, 1967; Johnson and Malvin, 1977). In
addition, the results showed that infusion of All at rates of 0.1, 1 and
5 ng.min ^ failed to stimulate proximal tubular fluid reabsorption. One
possible explanation for the lack of a stimulatory effect on proximal
reabsorption or an antinatriuretic effect of low doses of All is that
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the animals used in the present study were insufficiently sodium loaded
to supress endogenous All production. However, in order to ensure a
marked sodium loading, animals in group 2 were given 2% NaCl to drink
(instead of tap water) for at least five weeks prior to the experiments.
Although plasma or intrarenal All levels were not measured (viable All
radioimmunoassay not available), it is possible that such a degree of
sodium loading failed to sufficiently suppress endogenous All production
to allow the infused hormone to elicit an increase in proximal tubular
reabsorption and an antinatriuresis. Indeed, Mendelsohn (1979; 1982)
reported that in rats, intrarenal All levels were disassociated from
plasma renin activity and kidney renin concentrations during sodium
loading, ie, sodium loading depressed plasma renin activity and kidney
renin concentration but did not alter intrarenal All.
However, it is possible that sodium loading did suppress
endogenous All production, but that subsequent induction of Inactin
anaesthesia and/or surgical stress may have raised circulating and/or
intrarenal All levels and thus offset the prior effect of sodium loading
on endogenous angiotensin production. Indeed, it has been reported that
Inactin anaesthesia and surgical stress both increase sympathetic
activity and that this increases renin secretion and circulating All and
catecholamine levels (Davis and Freeman, 1976, Fray et al., 1976; Keeton
and Campbell, 1980; Tucker et al., 1982; Walker et al., 1983).
Therefore, in the present study, anaesthesia and /or surgical stress may
have offset the effect of prior sodium loading on endogenous All
production, thereby obscuring any stimulatory effect on proximal reab¬
sorption, or any antinatriuretic effect of infusion of low doses of the
peptide. Another possibility is that the doses of All infused were too
low to elicit an increase in proximal reabsorption and/or a pronounced
antinatriuresis. Alternatively, systemic All may not have such actions.
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The effects of alterations in sodium intake on renal function have
been examined extensively. Hall et al. , (1980a and 1980b) increased
sodium intake from 5 to 495 mEq per day in normal conscious dogs and
observed that urinary sodium excretion, RBF and GFR increased
significantly. These changes occurred in the absence of alterations in
arterial blood pressure. Other studies have failed to demonstrate an
effect of altered sodium intake on RBF, GFR or sodium excretion (Fagard
et al., 1978; Luft et al., 1979; Schor et al., 1980; Wong and Zimmerman,
1982). Wong and Zimmerman (1982) reported that arterial pressure, RBF
and RVR were unaltered by changes in dietary sodium intake in studies
using conscious dogs.
However, Coelho (1974) and Bonvalet et al., (1977) showed that rats
fed a high salt diet or salt loaded by saline infusion exhibited
significant increases in GFR of both superficial and deep nephrons. In
addition, Mendelsohn (1979; 1982) showed that in conscious rats, oral
saline loading increased urine flow, urinary sodium concentration and
sodium excretion without altering GFR. Sodium loading suppressed plasma
renin activity and kidney renin concentration but did not alter
intrarenal All concentration. However, sodium deprivation was found to
decrease urinary sodium concentration and increase plasma renin activity
and intrarenal All and renin concentrations. Indeed, intrarenal All
concentration was found to be inversely related to urinary sodium
concentration during sodium deprivation (Mendelsohn, 1979;1982). These
findings taken together with data from studies using blockers/antagonists
of the renin-angiotensin system (Kimbrough et al. , 1977;
Lohmeier et al. 1977), support the concept that the renin-angiotensin
system exerts an important role in the regulation of GFR and sodium
excretion during sodium deprivation. However, the finding by Mendelsohn
(1979; 1982) that sodium loading did not suppress intrarenal All levels
(ie, that the relationship between sodium balance and intrarenal All was
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non-linear) suggest that other mechanisms are involved in the regulation
of sodium excretion during salt loading.
Chronic increases in dietary sodium intake have been found not to
significantly alter plasma protein or electrolyte levels despite
reducing plasma renin activity and plasma aldosterone concentration
(Hall et al. , 1980a; 1980b; Haberle and Davis, 1982). However, Haberle
and Davis (1982) reported that after about two weeks salt loading rats
exhibited significant increases in urine flow, GFR and plasma volume.
Thus, dietary sodium loading as well as infusion of isotonic saline or
plasma appears to result in extracellular fluid volume expansion.
Extracellular fluid volume expansion due to dietary sodium loading
or infusion of isotonic saline or plasma has been shown to increase
urinary sodium and water excretion (Landwehr et al., 1967; Bank, 1970;
Haberle and Davis, 1982; Knox and Haas, 1982; Knox et al, 1983). The
possible mechanisms whereby volume expansion increases urinary sodium
and water excretion are discussed in Section 6.
In the present study the two experimental groups of animals were
subjected to different degrees of sodium loading. Despite this, the
control values for arterial blood pressure, urine flow, urinary sodium
excretion, sodium reabsorption and proximal Jv in the two groups were
not significantly different. In addition, values for urine flow and
sodium excretion obtained during the control periods in both groups were
not different from those observed during the control periods in the
non-sodium loaded animals (groups 1,2, and 3, Section 4). In this
respect, it is not clear why the control urine flow and sodium excretion
rates in the sodium loaded animals were not significantly higher than
the corresponding values in the non-sodium loaded rats (Section 4).
However it is possible that anaesthesia and/or surgical stress may
impair the ability of the kidney to excrete sodium.
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As a viable All radioimmunoassay was not available, neither plasma
nor intrarenal All levels were measured in either the present study or
the experiments reported in the previous section. However, the present
results are consistent with the possibility that in anaesthetised normal
(ie, not sodium loaded or depleted) or chronically sodium loaded rats
prepared for micropuncture, endogenous angiotensin production is not
suppressed and that All is still produced in amounts almost optimal for
maximal stimulation of proximal tubular fluid reabsorption and sodium
retention (Barraclough et al., 1967; Mendelsohn, 1979; 1982).
Recently, Radhi et al. , (1982) demonstrated the antinatriuretic
effect of low doses of All in anaesthetised surgically stressed rats.
However, they carried out their study on acutely volume expanded rats
(ie, systemic infusion of isotonic saline at a rate of about 12 ml.
hr ^; equivalent to 44-52 ml.kg ^.hr ^). Therefore, it is possible that
acute saline volume expansion may suppress endogenous All production in
the anaesthetised rat and thus allow the demonstration of a stimulatory
effect on proximal tubular fluid reabsorption and an antinatriuretic
effect of low doses of exogenous peptide.
SECTION 6
THE RENAL EFFECTS OF ANGIOTENSIN II
AND CAPTOPRIL IN ACUTELY VOLUME EXPANDED
CHRONICALLY SODIUM LOADED RATS
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INTRODUCTION
The experiments reported in Section 5 failed to demonstrate a
stimulation of proximal reabsorption or a pronounced antinatriuresis in
response to infusion of low doses of All in anaesthetised sodium loaded
rats. As discussed in the previous section, it is possible that the
doses of All infused were too low to elicit an increase in proximal
reabsorption and/or a pronounced antinatriuresis. Alternatively,
systemic All may not have such actions. However, another possibility is
that endogenous angiotensin production was not sufficiently suppressed
to allow the infused hormone to elicit an increase in proximal
reabsorption and/or a pronounced antinatriuresis.
Radhi et al., (1982) using an anesthetised rat preparation, reported
that systemic infusion of low doses of All (20 and 50 ng.kg .min )
resulted in significant reductions in both urine flow and sodium excre¬
tion rate. However, their experiments were performed on acutely volume
expanded animals (ie, animals were infused with isotonic saline at a
rate of approximately 12 ml.hr ^). Therefore, it is possible that acute
extracellular fluid volume expansion may sufficiently suppress endogenous
angiotensin II production in the anaesthetised surgically stressed rat,
to facilitate the demonstration of an antinatriuretic effect of low
doses of the peptide.
The experiments reported in this section were designed to determine
the effects of intravenous infusion of low (sub-pressor) doses of All on
renal function in the anaesthetised chronically sodium loaded and
acutely volume expanded rat. In addition, a second series of experiments
were carried out to evaluate the renal effects of systemic infusion of
the angiotensin-converting enzyme inhibitor, captopril (SQ 14,225), and
of infusion of All during continuing converting enzyme blockade in the




Experiments were conducted on sodium loaded male Wistar rats
(250-310g) fed a standard rat diet. The animals were chronically sodium
loaded by allowing them free access to 2% saline for 10-16 days prior to
the experiment, and acutely volume expanded by infusing intravenously,
0.9% saline at a rate of 150 yl.min * (9 ml.hr 29-36 ml.kg ''.hr *)
throughout the duration of the experiment.
SURGICAL PROCEDURE
Rats were anaesthetised and prepared for micropuncture as described
in Section 2.
EXPERIMENTAL PROCEDURE
Following placement of the jugular cannulae, a priming injection of
1 ml of 0.9% saline was given to replace fluid loss during surgery and
0.9% saline was infused from both syringes (total rate of 150 yl.min ^).
Two groups of experiments employing different protocols were
performed.
Group 1 - Infusion of 5 and 10 ng.min ^ All (n = 5)
Upon completion of surgery, a priming dose (1 ml of 2% solution) of
Inutest was administered through one of the jugular cannulae. A 1%
Inutest solution was then infused from one syringe at 75 yl.min *
throughout the remainder of the experiment. A period of 90 minutes was
then allowed for the attainment of steady state conditions. This
stabilisation period was followed by a 60 minute control period during
which the animals received infusions only of saline and Inutest. In the
two subsequent 60 minute periods, All was added to the saline syringe
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and administered at doses of 5 and 10 ng.min There then followed a
final 60 minute recovery period during which only saline and Inutest
were infused.
During each 60 minute infusion period, micropuncture procedures
were carried out to determine proximal tubular reabsorption (Jv) in
randomly selected surface proximal tubules. These procedures are
described in Section 2.
Group 2 - Infusion of CEI (Converting Enzyme Inhibitor) and CEI + All
(n = 6)
14
C inulin (Amersham) was used as the clearance marker for measure¬
ment of GFR. Following surgery, a priming dose (1 ml of 4.6 KBq - 0.124
14
yCi) of C inulin was administered through one of the jugular cannulae.
14 -1
C inulin was then infused (75 yl.min ) continuously during the
experiment at the rate of 0.344 KBq.min * (0.009 yCi.min ^). A 90
minute equilibration period was then allowed for the animals to reach
steady state conditions before urine collections were initiated. This
equilibration period was followed by a 60 minute control period during
14
which the animals received only saline and C inulin. A priming dose
(1 mg dissolved in 0.5 ml saline) of converting enzyme inhibitor (CEI)
(captopril, SQ14,225) was then administered intravenously through the
cannula previously used for infusion of saline alone. CEI was infused
through this cannula at the rate of 7.5 yg.min * throughout the
remainder of the experiment. A period of 30 minutes was allowed for
attainment of maximum converting enzyme blockade and stabilisation of
renal function before initiating a further 60 minute (CEI) period of
urine collections. All was then added to the CEI infusion and adminis¬
tered at a rate of 10 ng.min * during the third period (CEI + All).
The effectiveness of converting enzyme inhibition was checked by the
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abolition of the pressor response to bolus injections of 50 ng of AI
(1 ng.yl given before and after administration of CEI.
In both groups, the total rate of fluid administration remained
constant (150 yl.min ^). Twenty minute urine collections were made
during each 60 minute infusion period in both groups of animals. At the
mid-point of each 60 minute infusion period, an arterial blood sample
(400 yl.) was taken. The cells were separated by centrifugation and the
plasma removed. An aliquot of blood was used for estimations of arterial
haematocrit. At the end of each experiment, the left kidney was
removed, blotted dry and weighed.
146
RESULTS
MEAN ARTERIAL BLOOD PRESSURE
In group 1, infusion of All at rates of 5 and 10 ng.min ^ did not
increase arterial blood pressure. However, during the final recovery
period, arterial blood pressure decreased to 101.6 ± 4.8 mmHg, a value
significantly lower (P<0.05) than during the control period (120.2 ± 2.9
mmHg) (Fig. 30).
Bolus injections of 50 ng of AI (1 ng.yl;n=5) given before
administration of CEI resulted in a mean increase in MABP of 27.6 ± 1.0
mmHg while bolus injections of 50 ng of AI given 30 minutes (n=5) and 90
minutes (n=5) after CEI administration produced no measureable increase
in MABP. Thus, the dose of CEI used in the present study resulted in
the complete abolition of the pressor response to bolus injections of 50
ng of AI.
Administration of captopril resulted in a significant decrease in
arterial blood pressue from 128.6 ± 3.0 to 115.9 1 2.9 mmHg (P<0.05).
When All was added to the CEI infusate, arterial blood pressure
increased to 133.3 ± 5.5 mmHg, a value not significantly different from
the control value (Fig. 30).
URINE FLOW
The data presented in Fig. 31 show that in group 1, urine flow rate
was reduced from 25.39 ± 5.41 yl.min ^ during the control period to
17.73 ± 2.97 (P<0.05) during infusion of 5 ng.min ^ All and 15.41 ± 3.08
yl.min ^ (P<0.05) during infusion of 10 ng.min ^ All. During the
recovery period, urine flow rate was 18.9 ± 4.69 yl.min \ a value not
significantly different from that observed during the control period or
during the 5 and 10 ng.min ^ All infusion periods.
In group 2, urine flow rate increased in five rats and decreased
in one rat during the CEI infusion period. Thus, mean urine flow rate
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FIG 30 THE EFFECT OF All CEI AND CEU All ON
MEAN ARTERIAL BLOOD PRESSURE
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during the CEI infusion period (41.7 ± 9.79 yl.min was not
significantly different from that during the control period (29.79 ±
6.02 yl.min *). Addition of All to the CEI infusate decreased urine
flow rate to 16.01 ± 3.94 yl.min \ a value significantly lower than
that observed during both the control and CEI infusion periods (P<0.05
in both cases).
GLOMERULAR FILTRATION RATE (GFR)
Data obtained for glomerular filtration rate are presented in Fig.
32. Although glomerular filtration rate decreased from 0.97 ± 0.25 ml.
min ^.g ^ during the control period to 0.87 ± 0.21 and 0.73 ± 0.17 ml.
min ^.g ^ during the 5 and 10 ng.min ^ All infusion periods, the de¬
creases were not statistically significant. During the recovery period,
GFR was 0.86 ± 0.09 ml.min .g , a value not significantly different
from the control value.
Infusion of captopril resulted in a small but insignificant increase
in GFR from 1.13 ± 0.06 ml.min ^.g ^ during the control period to 1.23 ±
0.05 ml.min *.g Addition of All to the CEI infusion resulted in a
decrease in GFR to 0.88 ± 0.08 ml.min *.g a value significantly lower
than during both the control and CEI infusion periods (P<0.05 in both
cases) .
SODIUM EXCRETION RATE
In group 1 (Fig. 33), sodium excretion rate was 3.13 ± 0.40
ymol.min ^ during the 5 ng.min ^ All infusion period, a value not
significantly different from the control value (4.54 ± 0.84 ymol.min ^).
Infusion of All at 10 ng.min ^ reduced sodium excretion rate to 2.73 ±
0.47 ymol.min a value significantly lower than the control value
(P<0.05). During the recovery period, sodium excretion was 3.85 ± 0.97
ymol.min \ a value not significantly different from the control value.
FIG 32 THE EFFECT OF All CEI AND CEUAD ON
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FIG 33 THE EFFECT OF AII.CEl AND CEI ♦ All ON
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Infusion of captopril resulted in a marked increase (P<0.05) in
sodium excretion rate from 4.99 ± 0.59 ymol.min * during the control
period to 8.04 ± 1.43 ymol.min The natriuresis induced by captopril
was completely reversed by the addition of All to the CEI infusate.
During the infusion of CEI and All, sodium excretion was reduced to 3.07
± 0.69 ymol.min a value significantly lower than that observed during
both the control and CEI infusion periods (4.99 ± 0.59 and 8.0 ± 1.43
ymol.min * respectively, P<0.05 in both cases). These results are shown
in Fig. 33.
PERCENTAGE OF FILTERED SODIUM WHICH WAS REABSORBED
The results presented in Fig. 34 show that there was no significant
change in this parameter during the 5 and 10 ng.min ^ All infusion exper¬
iments. However, sodium reabsorption decreased from 96.18 ± 0.39 to
94.34 ± 0.93% of filtered load (P<0.05) during CEI infusion. Infusion
of All during converting enzyme blockade increased fractional sodium
reabsorption to 96.96 ± 0.44% of filtered load, a value significantly
higher (P<0.05) than that observed during the CEI infusion period (Fig.
34).
ABSOLUTE SODIUM REABSORPTION (Fig. 35)
Absolute sodium reabsorption did not vary significantly during the
5 and 10 ng.min * All infusion experiments. In group 2, infusion of
captopril resulted in a small but statistically insignificant increase
in absolute sodium reabsorption from 125.61 ± 5.21 to 133.48 ± 5.31
ymol.min . Addition of All to the CEI infusate reduced absolute sodium
reabsorption to 97.08 ± 10.70 ymol.min ^, a value significantly lower
than that observed during both the control and CEI infusion periods
(P<0.05 in both cases).
153
FIG 34 THE EFFECT OF All CEI AND CEUAI1 ON
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POTASSIUM EXCRETION RATE
The data obtained for this parameter are presented in Fig. 36. In
group 1, the potassium excretion rate decreased from 0.50 ± 0.10 ymol.
min ^ during the control period to 0.42 ± 0.06 (P<0.05) during infusion
of 5 ng.min ^ All and 0.41 ± 0.06 ymol.min ^ (P<0.05) during infusion of
10 ng.min ^ All. During the recovery period, mean potassium excretion
rate was 0.50 ± 0.06 ymol.min , a value not significantly different
from the control value.
In group 2, the potassium excretion rate was not significantly
altered during the CEI infusion. However, addition of All to the CEI
infusate resulted in a decrease in the absolute rate of potassium
excretion to 0.44 ± 0.10 ymol.min ^, a value significantly lower than
that during both the control and CEI infusion periods (0.69 ± 0.17 and
0.74 ± 0.15 ymol.min '''respectively, P<0.05 in both cases).
PERCENTAGE OF FILTERED POTASSIUM WHICH WAS EXCRETED
As illustrated in Fig. 37 no significant change in fractional
potassium excretion was observed in group 1. In group 2, fractional
potassium excretion during the CEI infusion period was 19.78 ± 4.08% of
the filtered load, a value not significantly different from the control
value (19.38 ± 4.22%). During the CEI + All infusion period, fractional
potassium excretion was 16.14 ± 3.45% of the filtered load, a value
significantly lower than that observed during the CEI infusion period
(p<0.05).
HAEMATOCRIT
As shown in Fig. 38 arterial haematocrit determined during the 5
ng.min ^ All infusion period (44.3 ± 0.7%) did not differ significantly
from the control value (44.7 ± 0.8%). However, haematocrit decreased
significantly to 41.7 ± 1.4% (P<0.05) during the 10 ng.min ^ All
infusion period and to 39.2 ± 1.1% (P<0.05) during the recovery period.
FIG 36 THE EFFECT OF All CEI AND CEUAB ON
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FIG 37 THE EFFECT OF AII.CEI AND CEI+AII ON
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In group 2, mean arterial haematocrit during the CEI infusion
period was 45.6 ± 0.7%, a value not significantly different from the
control value (46.9 ± 0.5%). During the CEI + All infusion period,
arterial haematocrit was 44.3 ± 1.3%, a value significantly lower than
that observed during the control period (P<0.05).
PROXIMAL TUBULAR FLUID REABSORPTION
In group 1, mean Jv during the control period was 1.71 ± 0.12 x
-4 3 -2 -1
10 mm .mm .sec , a value somewhat lower than the corresponding values
presented in Sections 3, 4 and 5. As shown in Fig. 39, there were no
significant changes in mean Jv during the 5 and 10 ng.min ^ All infusion
experiments.
Due to technical difficulties, no micropuncture data were obtained
from the CEI + All infusion experiments (group 2).
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FIG 39 THE EFFECT OF All ON MEAN PROXIMAL
TUBULAR FLUID REABSORPTION (J v(a))
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DISCUSSION
The present study showed that in the acutely volume expanded,
chronically sodium loaded rat, systemic infusion of All at a rate of 10
ng.min * (40 ng.kg *.min *) significantly reduced urine flow and urinary
sodium and potassium excretion without significantly altering GFR or
sodium reabsorption. Moreover, the reductions in urine flow and sodium
excretion observed during the 10 ng.min * All infusion period (Fig.
31-36) occurred in the absence of significant alterations in the rate of
proximal tubular fluid reabsorption. Thus, as for the results from
Section 5, the data obtained from the 5 and 10 ng.min * All experiments
(group 1) do not support the concept that the mechanism whereby systemic
All reduces urine flow and urinary sodium excretion involves a direct
stimulatory effect of the peptide on proximal tubular fluid reabsorption
However, it is possible that the peptide may have stimulated tubular
reabsorption by more distal segments of the nephron.
As discussed in Sections 4 and 5, the anaesthetised rat may produce
amounts of All that are optimal for maximal stimulation of proximal
tubular reabsorption, and that it may be necessary to suppress
endogenous angiotensin production in order to observe an increase in
proximal reabsorption and a pronounced antinatriuresis in response to
infusion of exogenous hormone. In the present study, rats were chroni¬
cally sodium loaded for 10-14 days prior to the experiments and received
a high rate of intravenous saline infusion (approximately 9 ml.hr
throughout the experiment. However, in group 1, infusion of All at a
rate of 10 ng.min ^ did not significantly alter the rate of proximal
tubular fluid reabsorption, despite reducing both urine flow and urinary
sodium excretion. Thus, it is possible that endogenous angiotensin
production was not sufficiently suppressed to allowT infused hormone to
elicit an increase in proximal tubular fluid reabsorption.
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Alternatively, systemic All may not have a stimulatory action on
proximal tubular fluid reabsorption. However, another possibility is
that endogenous All production was suppressed and that the infused
hormone did stimulate proximal tubular sodium reabsorption. This
increase may have been masked by an inhibitory effect of acute saline
loading on proximal tubular fluid reabsorption.
Since a viable All assay was not available, kidney and plasma All
concentrations were not determined in the present study. Thus, it is
not known what plasma or kidney All concentrations were, or to what
levels they were raised by the doses of All infused in the present
study.
Extracellular fluid volume expansion due to dietary sodium loading
or infusion of isotonic saline results in a decrease in renal sodium and
water reabsorption and an increase in sodium and water excretion (De
Wardener et al., 1961; Earley and Friedler, 1964; Landwehr et al., 1967;
Bank, 1970; Knox and Haas, 1982). Although volume expansion has been
shown to decrease renal vascular resistance and increase renal blood
flow (Barger et al. , 1961; Earley and Friedler, 1965) there is no
convincing evidence that an increase in renal blood flow per se is
responsible for the natriuresis. Indeed, Hartupee et al., (1982)
demonstrated that renal arterial infusion of acetylcholine increased
renal blood flow, renal interstitial pressure and urinary sodium excre¬
tion. However, when the increase in interstitial pressure was prevented
by decapsulation of the kidney and partial aortic clamping, the acetyl-
choline-induced vasodilation did not result in an increase in urinary
sodium excretion.
The natriuresis which follows volume expansion has been shown to be
independent of changes in glomerular filtration rate and circulating
adrenocortical hormone and ADH levels (De Wardener et al. , 1961; Levinsky
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and Lalone, 1963; Rector et al., 1964; Earley and Friedler, 1965). In
addition, although some studies have shown that volume expansion is
associated with the redistribution of renal blood flow or glomerular
filtration rate (Munck et al., 1970; Blantz et al., 1971; de Rouffignac
and Bonvalet, 1970; Jamison and Lacy, 1971) others have shown no redistr¬
ibution of blood flow and filtrate during volume expansion (Carriere et
al., 1972; Bruns et al., 1974; Coelho, 1974; Kinney and Di Scala, 1974).
It is well established that chronic and acute volume expansion
result in a decrease in sodium and water reabsorption by the proximal
tubule, and that the increase in urinary sodium and water excretion
observed during volume expansion is due largely to the decreased rate of
tubular reabsorption by this segment of the nephron (Giebisch et al. ,
1964; Cortney et al., 1965; Dirks et al., 1965; Watson,1966; Landwehr et
al., 1967; Rector et al., 1967; Bank et al., 1969; Bank, 1970; Knox and
Haas, 1982). Although the precise mechanism for this decrease in
proximal reabsorption is unclear, it has been suggested that it is
mediated primarily by altered intrarenal physical factors, especially
peritubular capillary and interstitial hydrostatic pressure (Martino and
Earley, 1967; Bank et al., 1969; Earley and Schrier, 1973; Fitzgibbons
et al., 1974; Osgood et al., 1977; Marchand, 1978; Knox and Haas, 1982).
There is evidence that reduced sympathetic nervous system activity
(ie, reduced efferent renal sympathetic nerve activity and reduced
circulating catecholamine levels) or increased secretion of a natriuretic
hormone may also be involved in mediating the decrease in proximal
reabsorption associated with volume expansion (De Wardener, 1978; Knox
et al., 1983; Di Bona 1982; Knox and Haas, 1982). However, the role for
such factors remains unclear. Indeed, it has been demonstrated that
reducing renal artery pressure prior to volume expansion prevents the
decrease in proximal tubular reabsorption and the increases in interst¬
itial hydrostatic pressure and sodium excretion (Bank et al., 1969;
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Fitzgibbons et al., 1974; Osgood et al., 1977; Marchand, 1978). These
results provide suggestive evidence against an important role for a
reduction in sympathetic nervous system activity or a circulating
hormone as mediators of the decrease in proximal reabsorption and the
natriuresis associated with volume expansion.
In the present study, proximal tubular fluid reabsorption was
estimated using the shrinking droplet micropuncture technique. The
shrinking droplet involves net volume reabsorption and is subject to
altered peritubular physical forces (Sato, 1975). Thus, although All
might, in the present study, have stimulated proximal tubular sodium
reabsorption, the finding that systemic All did not significantly alter
proximal tubular fluid reabsorption may have been due to an inhibitory
effect of saline volume expansion on tubular fluid reabsorption.
Therefore, use of methods for determining proximal tubular sodium
reabsorption, as opposed to tubular fluid reabsorption, such as the
stationary droplet microperfusion technique, may, in the future, resolve
this. The stationary droplet microperfusion technique separates trans-
epithelial sodium and water movement from transendothelial fluid uptake
and allows the measurement of active sodium transport. Unlike the
shrinking droplet, which involves net volume flux and is subject to
inhibition by increased peritubular capillary hydrostatic pressure, the
stationary droplet is probably not affected by changes in peritubular
capillary hydrostatic pressure.
Infusion of the converting enzyme inhibitor, captopril (SQ 14,225),
resulted in small but insignificant increases in glomerular filtration
rate and urine flow and significant increases in sodium and potassium
excretion and a marked decrease in the fraction of filtered sodium which
was reabsorbed (Fig. 31-35). These responses occurred despite a signifi¬
cant decrease in arterial blood pressure. These results are in good
agreement with previous reports concerning the characteristics of
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converting enzyme inhibition in rats (Thurston and Swales, 1978; Ploth
et al., 1979; Huang et al., 1981; Harris and Munro, 1984). Infusion of
All (10 ng.min during continuing converting enzyme blockade restored
arterial blood pressure and fractional sodium reabsorption to control
levels and produced significant reductions in glomerular filtration
rate, urine flow and urinary sodium and potassium excretion (Fig.
30-36). The reduction in absolute sodium reabsorption that occurred
during the CEI + All infusion period may be explained on the basis of a
reduced GFR and filtered sodium load and may not be due to an All
mediated reduction in tubular reabsorption. Indeed, addition of All to
the CEI infusate significantly increased the percentage of filtered
sodium which was absorbed.
Thus, during continuous blockade of endogenous All production,
infusion of the peptide at a rate of 10 ng.min ^ resulted in a signif¬
icant antidiuresis and antinatriuresis. These changes may have been
effected entirely by the concomitant reduction in GFR. However, it is
also possible that All exerted a stimulatory action on tubular
reabsorption and that this may have contributed to the decrease in
sodium and water excretion. Such an action is indicated since
fractional sodium reabsorption increased significantly during the CEI
and All infusion period.
As All has been shown to stimulate aldosterone secretion (Laragh
and Sealey, 1973; Hall et al., 1979b; MaCaa, 1982), it is possible that
the effects of captopril and All could be mediated by changes in aldos¬
terone secretion. Indeed, it has been demonstrated that infusion of
captopril in conscious dogs reduces plasma aldosterone concentration and
that infusion of All during continuing converting enzyme blockade
restores plasma aldosterone to control levels (Hall et al., 1979b;
MaCaa, 1982). However, infusion of aldosterone during captopril infusion
has been found not to significantly alter renal function from the values
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observed during captopril infusion alone (Hall et al., 1979b; MaCaa,
1982). In the present study, the natriuresis observed during captopril
administration and the decreases in sodium excretion observed during
infusion of All in both groups 1 and 2 were rapid in onset and readily
reversible, while the sodium retaining action of aldosterone is relat¬
ively slow and requires a latent period of 45 to 120 min before onset
(Barger et al., 1958; Ganong and Mulrow, 1958; Ludens and Fanestil,
1976). Similarly, aldosterone administration generally promotes sodium
retention and potassium loss, while in the present study, infusion of
All decreased potassium excretion to below control levels in both groups
1 and 2. Together, these results indicate that the effects of captopril
and All observed in the present study were not primarily mediated by
changes in aldosterone secretion.
There is a substantial body of evidence which favours the
hypothesis that the effects of converting enzyme inhibitors upon renal
function are due to the decreased production of All rather than to the
raised intrarenal concentrations of bradykinin and prostaglandins that
also accompany inhibition of kininase II (Marks et al. , 1980). This
evidence has been reviewed recently by Hollenberg (1982) and is further
supported by the findings that the renal responses to captopril or
teprotide were reversed by infusion of All (Hall et al., 1979b; MaCaa,
1982; Carmines et al., 1983; Harris and Munro, 1984). In addition, both
converting enzyme inhibition and infusion of the All receptor
antagonist, saralasin, have been found to produce similar changes in
renal function, characterised by vasodilation, increased glomerular
filtration rate, diuresis and natriuresis, despite an accompanying
reduction in systemic arterial pressure (Ploth et al., 1979; Ploth and
Roy, 1982a). Furthermore, it has been demonstrated that inhibition of
prostaglandin synthesis with indomethacin does not block the ability of
captopril to increase renal blood flow or glomerular filtration rate
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(Wong and Zimmerman, 1980; De Forrest, et al., 1982). The present
findings that infusion of All completely reversed the renal actions of
captopril provide further support for the hypothesis that the hypo¬
tensive and natriuretic actions of converting enzyme inhibitors are due
to inhibition of All formation and not to increased circulating and
renal concentrations of kinins and prostaglandins.
Mendelsohn (1979, 1982) reported that after oral sodium loading,
rats had suppressed plasma renin activity and kidney renin concentration
but unchanged intrarenal All levels. Therefore in the present study
despite chronic sodium loading and acute saline volume expansion, it is
possible that intrarenal All levels were not suppressed. Indeed,
infusion of captopril resulted in small but insignificant increases in
GFR and urine flow and a significant increase in sodium excretion. In
addition, infusion of All (10 ng.min ^) during continuing converting
enzyme blockade resulted in a significant antidiuresis and antinatriu-
resis. These results are consistent with the concept that under condit¬
ions of chronic sodium loading and acute volume expansion, endogenous
All production is not completely suppressed and that endogenous All is
still exerting sodium retaining actions on the kidney (Barraclough et
al., 1967; Mendelsohn, 1979; 1982).
If intrarenal All levels are not suppressed during chronic sodium
loading and/or acute volume expansion, then presumably factors other
than the altered status of the renin-angiotensin system are involved in
the regulation of sodium excretion under such conditions.
In summary, in the chronically sodium loaded rat receiving a high
rate of intravenous saline infusion, systemic infusion of sub-pressor
doses of All resulted in significant decreases in urine flow and urinary
sodium and potassium excretion. These changes occurred in the absence
of significant alterations in either GFR or proximal tubular fluid
reabsorption. Under the same conditions, infusion of the converting
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enzyme inhibitor, captopril, resulted in increases in urinary sodium and
potassium excretion and a reduction in the percentage of filtered sodium
reabsorbed. These changes occurred despite a significant decrease in
systemic arterial blood pressure. Infusion of All (10 ng.min *) during
converting enzyme blockade reversed the renal responses to captopril and
caused significant decreases in GFR, urine flow and sodium excretion and
an increase in fractional sodium reabsorption. These results support
the concept that under conditions of chronic sodium loading and acute
volume expansion, All production is not completely suppressed and that
endogenous All still exerts sodium retaining actions on the kidney.
Although the results are consistent with the notion that All plays a
role in the regulation of renal function via actions on both the renal
vasculature and the renal tubules, the present study provides no evidence
in support of the concept that systemic All elicits a decrease in urine




As discussed in Section 1, it is clear that all the components
necessary for the generation of the active angiotensin peptides are
present in the kidney, that various structures within the kidney possess
receptors for angiotensin and that angiotensin exerts multiple actions
in the regulation of renal function.
The experiments described in this thesis were designed to
investigate the effects of exogenous and endogenous angiotensin on renal
function in the rat. The effects of alterations in circulating
angiotensin levels and the actions of angiotensin as circulating hormone
were assessed by evaluating the responses to systemic infusions of the
peptide. It was shown that a high dose of angiotensin resulted in a
marked increase in both urine flow and urinary sodium excretion. It
appeared that the natriuretic response was dependent upon the increase
in renal perfusion pressure. Although it was not possible to determine
the mechanism whereby an angiotensin induced increase in renal perfusion
pressure resulted in a diuresis and natriuresis it was suggested that it
involves an increase in GFR and/or a decrease in tubular reabsorption
secondary to increased capillary and/or interstital hydrostatic
pressure.
Infusion of small (sub-pressor) doses of angiotensin resulted in a
subtle antidiuresis and antinatriuresis when the effects of the peptide
were compared to the effects of infusion of saline alone. In addition,
infusion of All at a rate of 10 ng.min * was found to significantly
reduce glomerular filtration rate. These effects of the peptide occurred
in the absence of an increase in proximal tubular reabsorption. Indeed,
the effects of infusion of sub-pressor doses of All on proximal tubular
reabsorption were not signficantly different to the effects of saline
infusion alone. Infusion of small (sub-pressor) doses of All in acutely
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volume expanded, sodium loaded rats, resulted in significant reductions
in urine flow and urinary sodium excretion. These changes occurred in
the absence of significant alterations in GFR or proximal tubular fluid
reabsorption. Together, these results were interpreted as being consis¬
tent with the concept that in it's normal state, the rat produces almost
optimal antinatriuretic amounts of angiotensin in order to maintain
sodium homeostasis, and that it is necessary to suppress endogenous
angiotensin production in order to demonstrate a pronounced antinatriu¬
retic effect of the infused hormone. In addition, the results provided
no evidence in support of the concept that the mechanism whereby systemic
All reduces urine flow and sodium excretion involves a direct stimulatory
effect of the peptide on proximal tubular fluid reabsorption.
Infusion of the converting enzyme inhibitor captopril, in acutely
volume expanded, sodium loaded rats resulted in small but statistically
insignificant increases in urine flow and GFR, a significant increase in
sodium excretion and a decrease in the percentage of filtered sodium
that was reabsorbed. Infusion of All (10 ng.min during continuing
converting enzyme blockade resulted in significant decreases in urine
flow, urinary sodium excretion and GFR and a significant increase in the
percentage of filtered sodium that was reabsorbed. These findings were
interpreted as indicating that even under conditions of chronic sodium
loading and acute volume expansion, endogenous angiotensin still exerts
sodium retaining actions on the kidney. In addition, these results were
consistent with the possibility that under conditions of converting
enzyme inhibition, systemic All reduces urine flow and urinary sodium
excretion via actions on both the renal vasculature and renal tubules.
The data reported in this thesis are consistent with the concept
that angiotensin is involved in the regulation of glomerular filtration
rate, tubular reabsorption and urinary sodium and water excretion.
However, further studies are required to determine the precise site and
mechanism of action of angiotensin in the regulation of renal function.
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In addition, studies are required to evaluate the quantitative contri¬
bution of both intrarenally formed and circulating angiotensin in the
regulation of renal function.
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Pressure dependence of angiotensin-induced natriuresis in rats
By P. J. Harris and K. 1). Mitchell. Department of Physiology, University Medical
School. Teviot Place. Edinburgh EHH 9AG
Infusion of pressor doses of angiotensin 11 (All) causes a transient decrease in
urinary sodium and water excretion followed by marked natriuresis and diuresis
(Xavar & Langford. 1974). Although the initial phase of this response may be
explained by the concomitant decreases in r.b.f. and g.f.r.. the mechanism responsible
for the natriuresis remains unclear. The possibility of a direct action of angiotensin
on proximal tubular sodium reabsorption has been shown previously (Harris &
Young. 1977) and is supported by the study of Healy & Elliott (1971) who showed
that angiotensin-indueed natriuresis in rabbits occurs even when the increase in
blood pressure is prevented by haemorrhage.
Male Wistar rats (250-3(KI g) were anaesthetized with Inactin (120 mg/kg) and the
left kidney prepared for micropuncture (fIvory. Lingard & Young. 1974). A jugular
vein was cannulated for infusion of0-9 °0 saline (0075 ml/min) and for administration
of All (Hypertensin. Oiba). A cannula was placed in the exposed ureter and urine
collected during 20-min periods. The sodium concentration of the urine was
measured by flame photometry. The left femoral or carotid artery was cannulated
to enable measurement of mean arterial blood pressure (m.a.b.p.). In a control group
of animals (n = 6) saline was infused for an initial period and then All added to the
infusate and administered at the rate of 100 ng/min for 60 min. A second period of
saline infusion followed. Proximal tubular fluid reabsorption (Jv<a>) was measured
at intervals during each period using the shrinking droplet technique ((ivory. 1971).
In a second group of animals (n = 7) a snare was placed around the aorta between
the origins of the renal arteries. The snare was tightened during the infusion ofAll
to prevent the rise in systemic blood pressure from raising the perfusion pressure of
the left kidney. All data were analysed by Student's paired /-test. In the control group
m.a.b.p. increased from 112 4 + 5-4 mmHg during the control period to 136-0 + 58
during All infusion (P < 0-005). This was associated with an initial fall in urinary
sodium excretion (l'Sa. J'/zmoPmin) followed by a significant (P < 0-05) increase to
almost three times the control value. In the second group femoral arterial blood
pressure was not altered during AH infusion, while f~Na. I' was significantly reduced
(P < 0 05). No significant change in Jv<a> w as observed during All infusion in the first
group but a significant reduction (P < 0 05) occurred in the second group.
These data do not support the proposal that the mechanism of angiotensin-induced
natriuresis involves a direct action of angiotensin on sodium reabsorption at least in
the proximal tubule. In contrast to previous studies in the rabbit the natriuretic
response in the rat ap}>cars to be dependent upon the increase in m.a.b.p.
This work was supported by the M.R.C.
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more detailed investigation of possible medullary ac¬
tion of angiotensin II.
Furosemide Releases Renin in the Rat Kidney
when Prostacyclin Synthesis is Suppressed
Rooen Vanaonqen. Denis P. Manonev.
Anne E.Baraen. Anne M. Tunnev
University Department of Medicine. Royal Perth
Hospital. Penh. Western Australia
The effect of inhibiting prostaglandin synthesis by
indomethacm on basal and furosemide-sumulated re¬
nin secretion was examined in the isolated perfused rat
kidney. 6-xeto-PGF,,,, the stable PGI- derivative, was
measured by radioimmunoassay in urine collected from
the kidney before and during perfusion. Dunng perfu¬
sion. levels of 6-keto-PGF|„ were similar when mea¬
sured directly or after organic extraction and chromato¬
graphic separation. T rearmem of rats with mdometha-
an (3.0mg'kgj reduced 6-keto-PGF,,, excretion in the
isolated kidney from 121.3±39.1 to 15.1 ±6.6 pg/mm
(n * 9: p<0.02) but had no effect on basal renin secre¬
tion. Renal perfusion pressure, perfusate rlow rate and
vascular resistance were similar in mdomethacin-
treated and control rats. Mean urine rlow rate was lower
after mdomethacm treatment. Infusion of furosemide
(250ug,min) did not alter 6 keto-PGFm excretion m
control or lndomethacm-treared (p>0.05) rats. Al¬
though renin secretion was markedly increased during
furosemide infusion, there was no significant difference
between control (1.806 — 384ngAl/mmi and indometh-
acm-treated (2.310 ± 5 54 ngAI/rmni rats (p > 0.05). Pro¬
pranolol. inrused at a dose 18 ug/mm). which suppressed
a comparable rise m rerun secretion after isoproterenol
stimulation, did not impair the response to furosemide
in mdomethacm-treaied rats. These results demon¬
strate that furosemide-sumulated renin secretion in the
rat kidney does not require intact renal PGI- synthesis
and is independent of beta-adrenergic mechanisms.
The Role of Aagiottms ia the Regaiaboa of
Proximal Totoaiar Tnusport
P.J. Hams. JCD. Mitchell
Department of Physiology, University Medical
School. Teviot Place. Edinburgh. UK
Previous studies have shown that the stimulatory
action ofangiotensin II (All) on proximal reaesorption
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in the anaesthetised rat appears to be maximal at phys¬
iological concentrations. Higher doses of .All inhibit
reaosorption. We have examined the effects of i.v.
administration of subpressor doses of All on proximal
fluid reaosorpnon <Jv> and whole kidney function in
Inacun-aesthetised rats infused with saline at a moder¬
ate rate (75ui ■ mm"'). At 0.1.1.5. and 10ng mm"' All
had no significant effects on urine rlow or sodium excre¬
tion although with all doses GFR decreased. Jv
(x 10"4mm' • mm"' • sec"^ was measured by the shrink¬
ing droplet micropuncture technique. In 6 rats Jv de¬
creased from 2.64 — 0.32 dunng saline infusion to
2.22 ±0.26 (NS)dunng infusion of0.1 ng ■ mm"' All. In
a separate group of 7 rats Jv was reduced from
2.91 ±0.23 dunng saline infusion to 2—4-0.18 (NS)
with lng • mm"1 AIL 2—0±,0.24(NS) with 5ng • min"*
and 1.99±0.10 (p<0.05) with lOng • mm All. Thus in
the anaesthetised rat. small (subpressor) increases in
plasmaAll concentration have a dose-dependent inhib¬
itory action on proximal tubular reabsorption.
Role of Angiotensin II in Mediating the Actions
of the Renal Nerves in the Rat Kidney
E. J. Johns. R. K. Handa
Department of Physiology, The Medical School.
Birmingham. UK
The importance ofangiotensin II m modulating the
actions of the renal nerves in the regulation of renal
haemodvnamics and tubular sodium reabsorption was
examined. The renal nerves were stimulated to cause a
modest or no fall in renal blood tlow (RBF) in the
absence or presence ofcaptopnl. Rats were prepared for
study as previously described [Ball and Johns. J. En-
docr. 90: 60 (1982)]. Renal nerve stimulation caused a
15% fail in RBF. no change in glomerular nitration rate
(GFR) but reduced absolute and fractional sodium ex¬
cretions by 37 and 34%. respectively. During infusion of
captopnl (0.38 mAf/kg/h) stimulation of the nerves
caused a reduction of 16% in both RBF and GFR. a 31%
fall in absolute and only an 18% (all in fractional sodium
excretion. Nerve stimulation which did not change
RBF or GFR reduced absolute and fractional sodium
excretions by 26 and 23%, respectively, and captopnl
abolished these responses. These data support a role for
locally generated angiotensin II in the regulation of
GFR by acting preferentially at the efferent artenoie
